Loading...

Peter Carroll, MD

Title(s)Professor, Urology
SchoolSchool of Medicine
Address550 16th. Street
San Francisco CA 94158
Phone415-353-7098
vCardDownload vCard
    Other Positions
    Title(s)Chair, Urology


    Collapse Biography 
    Collapse Education and Training
    University of California, San FranciscoResidency School of Medicine -Urology

    Collapse Research 
    Collapse Research Activities and Funding
    Effectiveness of Early Stage Prostate Cancer Treatment
    NIH/NCI RC1CA146596Sep 30, 2009 - Aug 31, 2012
    Role: Principal Investigator
    UCSF KURe Career Development Program
    NIH/NIDDK K12DK083021Sep 30, 2008 - Jul 31, 2018
    Role: Co-Principal Investigator
    Male Reproductive Health Research Career Development Program
    NIH/NICHD K12HD053943Sep 30, 2006 - Sep 29, 2011
    Role: Principal Investigator
    Active Surveillance for Early Stage Prostate Cancer: Selection, Monitoring
    NIH/NCI R13CA121759May 5, 2006 - Apr 30, 2007
    Role: Principal Investigator
    Molecular Effects of Nutrition Supplements in Prostate
    NIH/NCI R01CA101042Jun 10, 2003 - May 31, 2009
    Role: Principal Investigator
    UCSF PROSTATE CANCER SPORE
    NIH/NCI P50CA089520Sep 25, 2000 - Jun 30, 2010
    Role: Principal Investigator
    Cancer Center Support Grant
    NIH/NCI P30CA082103Aug 5, 1999 - Sep 29, 2012
    Role: Co-Principal Investigator

    Collapse ORNG Applications 
    Collapse Clinical Trials
    Collapse Global Health
    Collapse Websites
    Collapse In The News

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Rapid Utilization of Telehealth in a Comprehensive Cancer Center as a Response to COVID-19. J Med Internet Res. 2020 Jun 21. Lonergan PE, Washington Iii SL, Branagan L, Gleason N, Pruthi RS, Carroll PR, Odisho AY. PMID: 32568721.
      View in: PubMed   Mentions:    Fields:    
    2. Risk Factors for Biopsy Reclassification over Time in Men on Active Surveillance for Early Stage Prostate Cancer. J Urol. 2020 Jun 10; 101097JU0000000000001186. Lonergan PE, Washington SL, Cowan JE, Zhao S, Nguyen HG, Shinohara K, Cooperberg MR, Carroll PR. PMID: 32519915.
      View in: PubMed   Mentions:    Fields:    
    3. Implementation of Germline Testing for Prostate Cancer: Philadelphia Prostate Cancer Consensus Conference 2019. J Clin Oncol. 2020 Jun 09; JCO2000046. Giri VN, Knudsen KE, Kelly WK, Cheng HH, Cooney KA, Cookson MS, Dahut W, Weissman S, Soule HR, Petrylak DP, Dicker AP, AlDubayan SH, Toland AE, Pritchard CC, Pettaway CA, Daly MB, Mohler JL, Parsons JK, Carroll PR, Pilarski R, Blanco A, Woodson A, Rahm A, Taplin ME, Polascik TJ, Helfand BT, Hyatt C, Morgans AK, Feng F, Mullane M, Powers J, Concepcion R, Lin DW, Wender R, Mark JR, Costello A, Burnett AL, Sartor O, Isaacs WB, Xu J, Weitzel J, Andriole GL, Beltran H, Briganti A, Byrne L, Calvaresi A, Chandrasekar T, Chen DYT, Den RB, Dobi A, Crawford ED, Eastham J, Eggener S, Freedman ML, Garnick M, Gomella PT, Handley N, Hurwitz MD, Izes J, Karnes RJ, Lallas C, Languino L, Loeb S, Lopez AM, Loughlin KR, Lu-Yao G, Malkowicz SB, Mann M, Mille P, Miner MM, Morgan T, Moreno J, Mucci L, Myers RE, Nielsen SM, O'Neil B, Pinover W, Pinto P, Poage W, Raj GV, Rebbeck TR, Ryan C, Sandler H, Schiewer M, Scott EMD, Szymaniak B, Tester W, Trabulsi EJ, Vapiwala N, Yu EY, Zeigler-Johnson C, Gomella LG. PMID: 32516092.
      View in: PubMed   Mentions:    Fields:    
    4. Impact of 68Ga-PSMA-11 PET on the Management of recurrent Prostate Cancer in a Prospective Single-Arm Clinical Trial. J Nucl Med. 2020 May 01. Fendler WP, Ferdinandus J, Czernin J, Eiber M, Flavell RR, Behr SC, Wu IK, Lawhn-Heath C, Pampaloni MH, Reiter RE, Rettig MB, Gartmann J, Murthy V, Slavik R, Carroll PR, Herrmann K, Calais J, Hope TA. PMID: 32358094.
      View in: PubMed   Mentions:    Fields:    
    5. Magnetic Resonance Imaging for the Detection of High-Grade Cancer in the Canary Prostate Active Surveillance Study. J Urol. 2020 Apr 28; 101097JU0000000000001088. Liss MA, Newcomb LF, Zheng Y, Garcia MP, Filson CP, Boyer H, Brooks JD, Carroll PR, Cooperberg MR, Ellis WJ, Gleave ME, Martin FM, Morgan T, Nelson PS, Wagner AA, Thompson IM, Lin DW. PMID: 32343189.
      View in: PubMed   Mentions:    Fields:    
    6. Variability of the Positive Predictive Value of PI-RADS for Prostate MRI across 26 Centers: Experience of the Society of Abdominal Radiology Prostate Cancer Disease-focused Panel. Radiology. 2020 Jul; 296(1):76-84. Westphalen AC, McCulloch CE, Anaokar JM, Arora S, Barashi NS, Barentsz JO, Bathala TK, Bittencourt LK, Booker MT, Braxton VG, Carroll PR, Casalino DD, Chang SD, Coakley FV, Dhatt R, Eberhardt SC, Foster BR, Froemming AT, Fütterer JJ, Ganeshan DM, Gertner MR, Mankowski Gettle L, Ghai S, Gupta RT, Hahn ME, Houshyar R, Kim C, Kim CK, Lall C, Margolis DJA, McRae SE, Oto A, Parsons RB, Patel NU, Pinto PA, Polascik TJ, Spilseth B, Starcevich JB, Tammisetti VS, Taneja SS, Turkbey B, Verma S, Ward JF, Warlick CA, Weinberger AR, Yu J, Zagoria RJ, Rosenkrantz AB. PMID: 32315265.
      View in: PubMed   Mentions:    Fields:    
    7. Expansile cribriform Gleason pattern 4 has histopathologic and molecular features of aggressiveness and greater risk of biochemical failure compared to glomerulation Gleason pattern 4. Prostate. 2020 May; 80(8):653-659. Greenland NY, Cowan JE, Zhang L, Carroll PR, Chan E, Stohr BA, Simko JP. PMID: 32220141.
      View in: PubMed   Mentions:    Fields:    
    8. Editorial Comment. J Urol. 2020 Jun; 203(6):1121. Carroll PR, Chu C. PMID: 32186448.
      View in: PubMed   Mentions:    Fields:    
    9. Evaluation of a vaccination training program for pharmacy graduands in Australia. Curr Pharm Teach Learn. 2020 Jul; 12(7):850-857. Carroll PR, Chen Y, Vicheth P, Webber P, Hanrahan JR. PMID: 32540047.
      View in: PubMed   Mentions:    Fields:    
    10. The New Surveillance, Epidemiology, and End Results Prostate with Watchful Waiting Database: Opportunities and Limitations. Eur Urol. 2020 Jan 21. Jeong CW, Washington SL, Herlemann A, Gomez SL, Carroll PR, Cooperberg MR. PMID: 31980309.
      View in: PubMed   Mentions:    Fields:    
    11. Reply by Authors. J Urol. 2020 04; 203(4):733. Schenk JM, Newcomb LF, Zheng Y, Faino AV, Zhu K, Nyame YA, Brooks JD, Carroll PR, Cooperberg MR, Dash A, Filson CP, Gleave ME, Liss M, Martin FM, Morgan TM, Nelson PS, Thompson IM, Wagner AA, Lin DW. PMID: 31951502.
      View in: PubMed   Mentions:    Fields:    
    12. MRI-Based Prostate-Specific Antigen Density Predicts Gleason Score Upgrade in an Active Surveillance Cohort. AJR Am J Roentgenol. 2020 03; 214(3):574-578. Washington SL, Baskin AS, Ameli N, Nguyen HG, Westphalen AC, Shinohara K, Carroll PR. PMID: 31913068.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    13. Development and pilot evaluation of a personalized decision support intervention for low risk prostate cancer patients. Cancer Med. 2020 01; 9(1):125-132. Belkora J, Chan JM, Cooperberg MR, Neuhaus J, Stupar L, Weinberg T, Broering JM, Tenggara I, Cowan JE, Rosenfeld S, Kenfield SA, Van Blarigan EL, Simko JP, Witte J, Carroll PR. PMID: 31714037.
      View in: PubMed   Mentions:    Fields:    
    14. Understanding the Major Factors Affecting Response Shift Effects on Health-Related Quality of Life: What the Then-Test Measures in a Longitudinal Prostate Cancer Registry. Clin Genitourin Cancer. 2020 Feb; 18(1):e21-e27. Ten Ham RMT, Broering JM, Cooperberg MR, Carroll P, Wilson LS. PMID: 31796344.
      View in: PubMed   Mentions:    Fields:    
    15. Active surveillance for intermediate-risk prostate cancer: yes, but for whom? Curr Opin Urol. 2019 11; 29(6):605-611. Overland MR, Washington SL, Carroll PR, Cooperberg MR, Herlemann A. PMID: 31436567.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    16. African American Race is Not Associated with Risk of Reclassification during Active Surveillance: Results from the Canary Prostate Cancer Active Surveillance Study. J Urol. 2020 04; 203(4):727-733. Schenk JM, Newcomb LF, Zheng Y, Faino AV, Zhu K, Nyame YA, Brooks JD, Carroll PR, Cooperberg MR, Dash A, Filson CP, Gleave ME, Liss M, Martin FM, Morgan TM, Nelson PS, Thompson IM, Wagner AA, Lin DW. PMID: 31651227.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    17. Update of the Standard Operating Procedure on the Use of Multiparametric Magnetic Resonance Imaging for the Diagnosis, Staging and Management of Prostate Cancer. J Urol. 2020 Apr; 203(4):706-712. Bjurlin MA, Carroll PR, Eggener S, Fulgham PF, Margolis DJ, Pinto PA, Rosenkrantz AB, Rubenstein JN, Rukstalis DB, Taneja SS, Turkbey B. PMID: 31642740.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansPHPublic Health
    18. Prostate cancer mortality and metastasis under different biopsy frequencies in North American active surveillance cohorts. Cancer. 2020 Feb 01; 126(3):583-592. Lange JM, Laviana AA, Penson DF, Lin DW, Bill-Axelson A, Carlsson SV, Newcomb LF, Trock BJ, Carter HB, Carroll PR, Cooperberg MR, Cowan JE, Klotz LH, Etzioni RB. PMID: 31639200.
      View in: PubMed   Mentions:    Fields:    
    19. Reply by Authors. J Urol. 2019 11; 202(5):958. Gross MD, Sedrakyan A, Bianco FJ, Carroll PR, Daskivich TJ, Eggener SE, Ehdaie B, Fisher B, Gorin MA, Hunt B, Jiang H, Klein EA, Marinac-Dabic D, Montgomery JS, Polascik TJ, Priester AM, Rastinehad AR, Viviano CJ, Wysock JS, Hu JC. PMID: 31364932.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    20. SPARED Collaboration: Patient Selection for Partial Gland Ablation in Men with Localized Prostate Cancer. J Urol. 2019 11; 202(5):952-958. Gross MD, Sedrakyan A, Bianco FJ, Carroll PR, Daskivich TJ, Eggener SE, Ehdaie B, Fisher B, Gorin MA, Hunt B, Jiang H, Klein EA, Marinac-Dabic D, Montgomery JS, Polascik TJ, Priester AM, Rastinehad AR, Viviano CJ, Wysock JS, Hu JC. PMID: 31144591.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    21. Germline testing in those at risk of prostate cancer. Can J Urol. 2019 Oct; 26(5 Suppl 2):31-33. Carroll PR, Witte JS, Parsons JK. PMID: 31629425.
      View in: PubMed   Mentions:    Fields:    
    22. Development of Treatments for Localized Prostate Cancer in Patients Eligible for Active Surveillance: U.S. Food and Drug Administration Oncology Center of Excellence Public Workshop. J Urol. 2020 01; 203(1):115-119. Weinstock C, Suzman D, Kluetz P, Baxley J, Viviano C, Ibrahim A, Jarow J, Sridhara R, Liu K, Carroll P, Eggener S, Hu JC, Hussain M, King M, Klein E, Kungel T, Makarov D, Pinto PA, Rini B, Roach M, Sandler H, Schlegel PN, Song D, Goldberg K, Pazdur R, Beaver JA. PMID: 31502940.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    23. A 17-Gene Genomic Prostate Score as a Predictor of Adverse Pathology in Men on Active Surveillance. J Urol. 2019 10; 202(4):702-709. Kornberg Z, Cooperberg MR, Cowan JE, Chan JM, Shinohara K, Simko JP, Tenggara I, Carroll PR. PMID: 31026214.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    24. Trends in Complementary and Alternative Medicine Use among Patients with Prostate Cancer. J Urol. 2019 10; 202(4):689-695. Zuniga KB, Zhao S, Kenfield SA, Cedars B, Cowan JE, Van Blarigan EL, Broering JM, Carroll PR, Chan JM. PMID: 31091175.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    25. Identification and Characterization of Circulating Tumor Cells in Men Who have Undergone Prostatectomy for Clinically Localized, High Risk Prostate Cancer. J Urol. 2019 10; 202(4):732-741. Friedlander TW, Welty C, Anantharaman A, Schonhoft JD, Jendrisak A, Lee J, Li P, Hough J, Stromlund A, Edwards M, Sangar S, Kobayashi Y, Simko J, Farrokhian N, Lindquist K, Greene S, Ontiveros P, Graf R, Rodriquez A, Suraneni M, Wang Y, Landers M, Carroll P, Cooperberg MR, Dittamore R, Paris PL. PMID: 31216253.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    26. Stability of a 17-Gene Genomic Prostate Score in Serial Testing of Men on Active Surveillance for Early Stage Prostate Cancer. J Urol. 2019 10; 202(4):696-701. Cedars BE, Washington SL, Cowan JE, Leapman M, Tenggara I, Chan JM, Cooperberg MR, Carroll PR. PMID: 30958742.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    27. Obesity at Diagnosis and Prostate Cancer Prognosis and Recurrence Risk Following Primary Treatment by Radical Prostatectomy. Cancer Epidemiol Biomarkers Prev. 2019 11; 28(11):1917-1925. Langlais CS, Cowan JE, Neuhaus J, Kenfield SA, Van Blarigan EL, Broering JM, Cooperberg MR, Carroll P, Chan JM. PMID: 31462398.
      View in: PubMed   Mentions:    Fields:    
    28. Decipher identifies men with otherwise clinically favorable-intermediate risk disease who may not be good candidates for active surveillance. Prostate Cancer Prostatic Dis. 2020 03; 23(1):136-143. Herlemann A, Huang HC, Alam R, Tosoian JJ, Kim HL, Klein EA, Simko JP, Chan JM, Lane BR, Davis JW, Davicioni E, Feng FY, McCue P, Kim H, Den RB, Bismar TA, Carroll PR, Cooperberg MR. PMID: 31455846.
      View in: PubMed   Mentions:    Fields:    
    29. Predicting Biopsy Outcomes During Active Surveillance for Prostate Cancer: External Validation of the Canary Prostate Active Surveillance Study Risk Calculators in Five Large Active Surveillance Cohorts. Eur Urol. 2019 Nov; 76(5):693-702. Drost FH, Nieboer D, Morgan TM, Carroll PR, Roobol MJ. PMID: 31451332.
      View in: PubMed   Mentions: 1     Fields:    
    30. Evaluating the Safety of Active Surveillance: Outcomes of Deferred Radical Prostatectomy after an Initial Period of Surveillance. J Urol. 2019 09; 202(3):506-510. Balakrishnan AS, Cowan JE, Cooperberg MR, Shinohara K, Nguyen HG, Carroll PR. PMID: 30958738.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    31. Guidelines should be assessed based on the underlying evidence. CMAJ. 2019 08 06; 191(31):E871. Carroll PR, Parsons JK. PMID: 31387962.
      View in: PubMed   Mentions:    Fields:    
    32. Hematuria Practice Guidelines That Explicitly Consider Harms and Costs. JAMA Intern Med. 2019 Jul 29. Bauer SR, Carroll PR, Grady D. PMID: 31355847.
      View in: PubMed   Mentions:    Fields:    
    33. Robust Health Utility Assessment Among Long-term Survivors of Prostate Cancer: Results from the Cancer of the Prostate Strategic Urologic Research Endeavor Registry. Eur Urol. 2019 12; 76(6):743-751. Jeong CW, Cowan JE, Broering JM, Ten Ham RMT, Wilson LS, Carroll PR, Cooperberg MR. PMID: 31345635.
      View in: PubMed   Mentions:    Fields:    
    34. Detection of clinically signifi cant prostate cancer with PIRADS v2 scores, PSA density, and ADC values in regions with and without mpMRI visible lesions. Int Braz J Urol. 2019 Jul-Aug; 45(4):713-723. Westphalen AC, Fazel F, Nguyen H, Cabarrus M, Hanley-Knutson K, Shinohara K, Carroll PR. PMID: 31136112.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    35. Automating the Capture of Structured Pathology Data for Prostate Cancer Clinical Care and Research. JCO Clin Cancer Inform. 2019 07; 3:1-8. Odisho AY, Bridge M, Webb M, Ameli N, Eapen RS, Stauf F, Cowan JE, Washington SL, Herlemann A, Carroll PR, Cooperberg MR. PMID: 31314550.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    36. Correlation of a Commercial Genomic Risk Classifier with Histological Patterns in Prostate Cancer. J Urol. 2019 07; 202(1):90-95. Greenland NY, Zhang L, Cowan JE, Carroll PR, Stohr BA, Simko JP. PMID: 30810466.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    37. A Mobile Health Intervention for Prostate Biopsy Patients Reduces Appointment Cancellations: Cohort Study. J Med Internet Res. 2019 06 02; 21(6):e14094. Balakrishnan AS, Nguyen HG, Shinohara K, Au Yeung R, Carroll PR, Odisho AY. PMID: 31199294.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    38. Assessment of 68Ga-PSMA-11 PET Accuracy in Localizing Recurrent Prostate Cancer: A Prospective Single-Arm Clinical Trial. JAMA Oncol. 2019 Jun 01; 5(6):856-863. Fendler WP, Calais J, Eiber M, Flavell RR, Mishoe A, Feng FY, Nguyen HG, Reiter RE, Rettig MB, Okamoto S, Emmett L, Zacho HD, Ilhan H, Wetter A, Rischpler C, Schoder H, Burger IA, Gartmann J, Smith R, Small EJ, Slavik R, Carroll PR, Herrmann K, Czernin J, Hope TA. PMID: 30920593.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCTClinical Trials
    39. Trends and Predictors of Adjuvant Therapy for Adverse Features Following Radical Prostatectomy: An Analysis From Cancer of the Prostate Strategic Urologic Research Endeavor. Urology. 2019 Sep; 131:157-165. Balakrishnan AS, Zhao S, Cowan JE, Broering JM, Cooperberg MR, Carroll PR. PMID: 31150694.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    40. The State of the Science on Prostate Cancer Biomarkers: The San Francisco Consensus Statement. Eur Urol. 2019 Sep; 76(3):268-272. Cooperberg MR, Carroll PR, Dall'Era MA, Davies BJ, Davis JW, Eggener SE, Feng FY, Lin DW, Morgan TM, Morgans AK, Spratt DE, Taneja SS, Penson DF. PMID: 31128968.
      View in: PubMed   Mentions: 1     Fields:    
    41. Single-Center Prospective Evaluation of 68Ga-PSMA-11 PET in Biochemical Recurrence of Prostate Cancer. AJR Am J Roentgenol. 2019 08; 213(2):266-274. Lawhn-Heath C, Flavell RR, Behr SC, Yohannan T, Greene KL, Feng F, Carroll PR, Hope TA. PMID: 31039025.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    42. Editorial Comment. J Urol. 2019 04; 201(4):820. Carroll P, Schmidt B. PMID: 30947462.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    43. Location of Recurrence by Gallium-68 PSMA-11 PET Scan in Prostate Cancer Patients Eligible for Salvage Radiotherapy. Urology. 2019 07; 129:165-171. Boreta L, Gadzinski AJ, Wu SY, Xu M, Greene K, Quanstrom K, Nguyen HG, Carroll PR, Hope TA, Feng FY. PMID: 30928607.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    44. Longitudinal Comparison of Patient-Level Outcomes and Costs Across Prostate Cancer Treatments With Urinary Problems. Am J Mens Health. 2019 Mar-Apr; 13(2):1557988319835326. Tang J, Zhong L, Paoli C, Paciorek A, Carroll P, Wilson L. PMID: 30836832.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    45. The Immune Landscape of Prostate Cancer and Nomination of PD-L2 as a Potential Therapeutic Target. J Natl Cancer Inst. 2019 03 01; 111(3):301-310. Zhao SG, Lehrer J, Chang SL, Das R, Erho N, Liu Y, Sjöström M, Den RB, Freedland SJ, Klein EA, Karnes RJ, Schaeffer EM, Xu M, Speers C, Nguyen PL, Ross AE, Chan JM, Cooperberg MR, Carroll PR, Davicioni E, Fong L, Spratt DE, Feng FY. PMID: 30321406.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    46. Genomic Prostate Score, PI-RADS™ version 2 and Progression in Men with Prostate Cancer on Active Surveillance. J Urol. 2019 02; 201(2):300-307. Kornberg Z, Cowan JE, Westphalen AC, Cooperberg MR, Chan JM, Zhao S, Shinohara K, Carroll PR. PMID: 30179620.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    47. Editorial Comment. J Urol. 2019 02; 201(2):298-299. Carroll P. PMID: 30634361.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    48. Performance of PCA3 and TMPRSS2:ERG urinary biomarkers in prediction of biopsy outcome in the Canary Prostate Active Surveillance Study (PASS). Prostate Cancer Prostatic Dis. 2019 09; 22(3):438-445. Newcomb LF, Zheng Y, Faino AV, Bianchi-Frias D, Cooperberg MR, Brown MD, Brooks JD, Dash A, Fabrizio MD, Gleave ME, Liss M, Morgan TM, Thompson IM, Wagner AA, Carroll PR, Nelson PS, Lin DW. PMID: 30664734.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    49. Genomic Risk Predicts Molecular Imaging-detected Metastatic Nodal Disease in Prostate Cancer. Eur Urol Oncol. 2019 11; 2(6):685-690. Xu MJ, Kornberg Z, Gadzinski AJ, Diao D, Cowan JE, Wu SY, Boreta L, Spratt DE, Behr SC, Nguyen HG, Cooperberg MR, Davicioni E, Roach M, Hope TA, Carroll PR, Feng FY. PMID: 31411984.
      View in: PubMed   Mentions:    Fields:    
    50. Feasibility, Acceptability, and Behavioral Outcomes from a Technology-enhanced Behavioral Change Intervention (Prostate 8): A Pilot Randomized Controlled Trial in Men with Prostate Cancer. Eur Urol. 2019 06; 75(6):950-958. Kenfield SA, Van Blarigan EL, Ameli N, Lavaki E, Cedars B, Paciorek AT, Monroy C, Tantum LK, Newton RU, Signorell C, Suh JH, Zhang L, Cooperberg MR, Carroll PR, Chan JM. PMID: 30638635.
      View in: PubMed   Mentions: 2     Fields:    
    51. Continued 5a-Reductase Inhibitor Use after Prostate Cancer Diagnosis and the Risk of Reclassification and Adverse Pathological Outcomes in the PASS. J Urol. 2019 01; 201(1):106-111. Kearns JT, Faino AV, Schenk JM, Newcomb LF, Brooks JD, Carroll PR, Dash A, Ellis WJ, Fabrizio M, Gleave ME, Morgan TM, Nelson PS, Thompson IM, Wagner A, Zheng Y, Lin DW. PMID: 30076904.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansPHPublic Health
    52. Impact of Staging 68Ga-PSMA-11 PET Scans on Radiation Treatment Plansin Patients With Prostate Cancer. Urology. 2019 03; 125:154-162. Wu SY, Boreta L, Shinohara K, Nguyen H, Gottschalk AR, Hsu IC, Roach M, Westphalen AC, Feng FY, Carroll PR, Chang AJ, Hope TA. PMID: 30580002.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    53. Metaanalysis of 68Ga-PSMA-11 PET Accuracy for the Detection of Prostate Cancer Validated by Histopathology. J Nucl Med. 2019 06; 60(6):786-793. Hope TA, Goodman JZ, Allen IE, Calais J, Fendler WP, Carroll PR. PMID: 30530831.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    54. Phase I Study of CTT1057, an 18F-Labeled Imaging Agent with Phosphoramidate Core Targeting Prostate-Specific Membrane Antigen in Prostate Cancer. J Nucl Med. 2019 07; 60(7):910-916. Behr SC, Aggarwal R, VanBrocklin HF, Flavell RR, Gao K, Small EJ, Blecha J, Jivan S, Hope TA, Simko JP, Kurhanewicz J, Noworolski SM, Korn NJ, De Los Santos R, Cooperberg MR, Carroll PR, Nguyen HG, Greene KL, Langton-Webster B, Berkman CE, Seo Y. PMID: 30464040.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    55. Effect of Increasing Levels of Web-Based Behavioral Support on Changes in Physical Activity, Diet, and Symptoms in Men With Prostate Cancer: Protocol for a Randomized Controlled Trial. JMIR Res Protoc. 2018 Nov 15; 7(11):e11257. Winters-Stone KM, Kenfield SA, Van Blarigan EL, Moe EL, Ramsdill JW, Daniel K, Macaire G, Paich K, Kessler ER, Kucuk O, Gillespie TW, Lyons KS, Beer TM, Broering JM, Carroll PR, Chan JM. PMID: 30442638.
      View in: PubMed   Mentions:
    56. Diagnostic Accuracy of 68Ga-PSMA-11 PET/MRI Compared with Multiparametric MRI in the Detection of Prostate Cancer. Radiology. 2018 12; 289(3):730-737. Hicks RM, Simko JP, Westphalen AC, Nguyen HG, Greene KL, Zhang L, Carroll PR, Hope TA. PMID: 30226456.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    57. A Prospective Adaptive Utility Trial to Validate Performance of a Novel Urine Exosome Gene Expression Assay to Predict High-grade Prostate Cancer in Patients with Prostate-specific Antigen 2-10ng/ml at Initial Biopsy. Eur Urol. 2018 12; 74(6):731-738. McKiernan J, Donovan MJ, Margolis E, Partin A, Carter B, Brown G, Torkler P, Noerholm M, Skog J, Shore N, Andriole G, Thompson I, Carroll P. PMID: 30237023.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCellsCTClinical Trials
    58. Consistent Biopsy Quality and Gleason Grading Within the Global Active Surveillance Global Action Plan 3 Initiative: A Prerequisite for Future Studies. Eur Urol Oncol. 2019 05; 2(3):333-336. van der Kwast TH, Helleman J, Nieboer D, Bruinsma SM, Roobol MJ, Trock B, Ehdaie B, Carroll P, Filson C, Kim J, Logothetis C, Morgan T, Klotz L, Pickles T, Hyndman E, Moore CM, Gnanapragasam V, Van Hemelrijck M, Dasgupta P, Bangma C, Roobol M, Villers A, Rannikko A, Valdagni R, Perry A, Hugosson J, Rubio-Briones J, Bjartell A, Hefermehl L, Shiong LL, Frydenberg M, Kakehi Y, Chung BH, van der Kwast T, Obbink H, van der Linden W, Hulsen T, de Jonge C, Kattan M, Xinge J, Muir K, Lophatananon A, Fahey M, Steyerberg E, Nieboer D, Zhang L, Guo W, Benfante N, Cowan J, Patil D, Tolosa E, Kim TK, Mamedov A, LaPointe V, Crump T, Kimberly-Duffell J, Santaolalla A, Nieboer D, Olivier JT, Rancati T, Ahlgren H, Mascarós J, Löfgren A, Lehmann K, Lin CH, Hirama H, Lee KS, Jenster G, Auvinen A, Bjartell A, Haider M, van Bochove K, Carter B, Gledhill S, Buzza M, Bangma C, Roobol M, Bruinsma S, Helleman J. PMID: 31200849.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    59. Comparing Prognostic Utility of a Single-marker Immunohistochemistry Approach with Commercial Gene Expression Profiling Following Radical Prostatectomy. Eur Urol. 2018 11; 74(5):668-675. Leapman MS, Nguyen HG, Cowan JE, Xue L, Stohr B, Simko J, Cooperberg MR, Carroll PR. PMID: 30181067.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    60. Practice patterns of primary EBRT with and without ADT in prostate cancer treatment. Prostate Cancer Prostatic Dis. 2019 03; 22(1):117-124. Schmidt B, Eapen RS, Cowan JE, Broering JM, Greene KL, Carroll PR, Cooperberg MR. PMID: 30171230.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    61. USPTF Prostate Cancer Screening Recommendations-A Step in the Right Direction. JAMA Surg. 2018 08 01; 153(8):701-702. Carroll PR. PMID: 29801146.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    62. Effect of Oscillation on Perineal Pressure in Cyclists: Implications for Micro-Trauma. Sex Med. 2018 Sep; 6(3):239-247. Sanford T, Gadzinski AJ, Gaither T, Osterberg EC, Murphy GP, Carroll PR, Breyer BN. PMID: 29936216.
      View in: PubMed   Mentions:
    63. The Diverse Genomic Landscape of Clinically Low-risk Prostate Cancer. Eur Urol. 2018 10; 74(4):444-452. Cooperberg MR, Erho N, Chan JM, Feng FY, Fishbane N, Zhao SG, Simko JP, Cowan JE, Lehrer J, Alshalalfa M, Kolisnik T, Chelliserry J, Margrave J, Aranes M, Plessis MD, Buerki C, Tenggara I, Davicioni E, Carroll PR. PMID: 29853306.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    64. Effects of Initial Gleason Grade on Outcomes during Active Surveillance for Prostate Cancer. Eur Urol Oncol. 2018 10; 1(5):386-394. Masic S, Cowan JE, Washington SL, Nguyen HG, Shinohara K, Cooperberg MR, Carroll PR. PMID: 31158077.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    65. Optimal Radical Therapy for Localized Prostate Cancer: Recreation of the Self-Fulfilling Prophecy With Combination Brachytherapy? J Clin Oncol. 2018 10 10; 36(29):2914-2917. Spratt DE, Carroll PR. PMID: 29782208.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    66. Heterogeneous Flare in Prostate-specific Membrane Antigen Positron Emission Tomography Tracer Uptake with Initiation of Androgen Pathway Blockade in Metastatic Prostate Cancer. Eur Urol Oncol. 2018 05; 1(1):78-82. Aggarwal R, Wei X, Kim W, Small EJ, Ryan CJ, Carroll P, Cooperberg M, Evans MJ, Hope T. PMID: 31100231.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    67. Development of a stress response therapy targeting aggressive prostate cancer. Sci Transl Med. 2018 05 02; 10(439). Nguyen HG, Conn CS, Kye Y, Xue L, Forester CM, Cowan JE, Hsieh AC, Cunningham JT, Truillet C, Tameire F, Evans MJ, Evans CP, Yang JC, Hann B, Koumenis C, Walter P, Carroll PR, Ruggero D. PMID: 29720449.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansAnimalsCells
    68. Role of Surveillance Biopsy with No Cancer as a Prognostic Marker for Reclassification: Results from the Canary Prostate Active Surveillance Study. Eur Urol. 2018 05; 73(5):706-712. Kearns JT, Faino AV, Newcomb LF, Brooks JD, Carroll PR, Dash A, Ellis WJ, Fabrizio M, Gleave ME, Morgan TM, Nelson PS, Thompson IM, Wagner AA, Zheng Y, Lin DW. PMID: 29433973.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    69. Refined Analysis of Prostate-specific Antigen Kinetics to Predict Prostate Cancer Active Surveillance Outcomes. Eur Urol. 2018 08; 74(2):211-217. Cooperberg MR, Brooks JD, Faino AV, Newcomb LF, Kearns JT, Carroll PR, Dash A, Etzioni R, Fabrizio MD, Gleave ME, Morgan TM, Nelson PS, Thompson IM, Wagner AA, Lin DW, Zheng Y. PMID: 29433975.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    70. Boolean analysis identifies CD38 as a biomarker of aggressive localized prostate cancer. Oncotarget. 2018 Jan 19; 9(5):6550-6561. Sahoo D, Wei W, Auman H, Hurtado-Coll A, Carroll PR, Fazli L, Gleave ME, Lin DW, Nelson PS, Simko J, Thompson IM, Leach RJ, Troyer DA, True LD, McKenney JK, Feng Z, Brooks JD. PMID: 29464091.
      View in: PubMed   Mentions: 1     Fields:    
    71. Scatter Artifact with Ga-68-PSMA-11 PET: Severity Reduced With Furosemide Diuresis and Improved Scatter Correction. Mol Imaging. 2018 Jan-Dec; 17:1536012118811741. Lawhn-Heath C, Flavell RR, Korenchan DE, Deller T, Lake S, Carroll PR, Hope TA. PMID: 31749411.
      View in: PubMed   Mentions:    Fields:    
    72. Associations of Luminal and Basal Subtyping of Prostate Cancer With Prognosis and Response to Androgen Deprivation Therapy. JAMA Oncol. 2017 12 01; 3(12):1663-1672. Zhao SG, Chang SL, Erho N, Yu M, Lehrer J, Alshalalfa M, Speers C, Cooperberg MR, Kim W, Ryan CJ, Den RB, Freedland SJ, Posadas E, Sandler H, Klein EA, Black P, Seiler R, Tomlins SA, Chinnaiyan AM, Jenkins RB, Davicioni E, Ross AE, Schaeffer EM, Nguyen PL, Carroll PR, Karnes RJ, Spratt DE, Feng FY. PMID: 28494073.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    73. Development and Validation of a Novel Integrated Clinical-Genomic Risk Group Classification for Localized Prostate Cancer. J Clin Oncol. 2018 02 20; 36(6):581-590. Spratt DE, Zhang J, Santiago-Jiménez M, Dess RT, Davis JW, Den RB, Dicker AP, Kane CJ, Pollack A, Stoyanova R, Abdollah F, Ross AE, Cole A, Uchio E, Randall JM, Nguyen H, Zhao SG, Mehra R, Glass AG, Lam LLC, Chelliserry J, du Plessis M, Choeurng V, Aranes M, Kolisnik T, Margrave J, Alter J, Jordan J, Buerki C, Yousefi K, Haddad Z, Davicioni E, Trabulsi EJ, Loeb S, Tewari A, Carroll PR, Weinmann S, Schaeffer EM, Klein EA, Karnes RJ, Feng FY, Nguyen PL. PMID: 29185869.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    74. Comparative Analysis of Biopsy Upgrading in Four Prostate Cancer Active Surveillance Cohorts. Ann Intern Med. 2018 01 02; 168(1):1-9. Inoue LYT, Lin DW, Newcomb LF, Leonardson AS, Ankerst D, Gulati R, Carter HB, Trock BJ, Carroll PR, Cooperberg MR, Cowan JE, Klotz LH, Mamedov A, Penson DF, Etzioni R. PMID: 29181514.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    75. Milk and other dairy foods in relation to prostate cancer recurrence: Data from the cancer of the prostate strategic urologic research endeavor (CaPSURE™). Prostate. 2018 Jan; 78(1):32-39. Tat D, Kenfield SA, Cowan JE, Broering JM, Carroll PR, Van Blarigan EL, Chan JM. PMID: 29105845.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimals
    76. Cycling, and Male Sexual and Urinary Function: Results from a Large, Multinational, Cross-Sectional Study. J Urol. 2018 03; 199(3):798-804. Awad MA, Gaither TW, Murphy GP, Chumnarnsongkhroh T, Metzler I, Sanford T, Sutcliffe S, Eisenberg ML, Carroll PR, Osterberg EC, Breyer BN. PMID: 29031767.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    77. Association between a 17-gene genomic prostate score and multi-parametric prostate MRI in men with low and intermediate risk prostate cancer (PCa). PLoS One. 2017; 12(10):e0185535. Leapman MS, Westphalen AC, Ameli N, Lawrence HJ, Febbo PG, Cooperberg MR, Carroll PR. PMID: 29016610.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    78. Circulating and intraprostatic sex steroid hormonal profiles in relation to male pattern baldness and chest hair density among men diagnosed with localized prostate cancers. Prostate. 2017 Dec; 77(16):1573-1582. Zhou CK, Stanczyk FZ, Hafi M, Veneroso CC, Lynch B, Falk RT, Niwa S, Emanuel E, Gao YT, Hemstreet GP, Zolfghari L, Carroll PR, Manyak MJ, Sesterhenn IA, Levine PH, Hsing AW, Cook MB. PMID: 28971497.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    79. Characterization and stratification of prostate lesions based on comprehensive multiparametric MRI using detailed whole-mount histopathology as a reference standard. NMR Biomed. 2017 Dec; 30(12). Starobinets O, Simko JP, Kuchinsky K, Kornak J, Carroll PR, Greene KL, Kurhanewicz J, Noworolski SM. PMID: 28961382.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    80. Impact of Lesion Visibility on Transrectal Ultrasound on the Prediction of Clinically Significant Prostate Cancer (Gleason Score 3 + 4 or Greater) with Transrectal Ultrasound-Magnetic Resonance Imaging Fusion Biopsy. J Urol. 2018 03; 199(3):699-705. Garcia-Reyes K, Nguyen HG, Zagoria RJ, Shinohara K, Carroll PR, Behr SC, Westphalen AC. PMID: 28941918.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    81. Validation of GEMCaP as a DNA Based Biomarker to Predict Prostate Cancer Recurrence after Radical Prostatectomy. J Urol. 2018 03; 199(3):719-725. Nguyen HG, Welty C, Lindquist K, Ngo V, Gilbert E, Bengtsson H, Magi-Galluzzi C, Jean-Gilles J, Yao J, Cooperberg M, Messing E, Klein EA, Carroll PR, Paris PL. PMID: 28941923.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    82. Optimal MRI sequences for 68Ga-PSMA-11 PET/MRI in evaluation of biochemically recurrent prostate cancer. EJNMMI Res. 2017 Sep 19; 7(1):77. Lake ST, Greene KL, Westphalen AC, Behr SC, Zagoria R, Small EJ, Carroll PR, Hope TA. PMID: 28929350.
      View in: PubMed   Mentions:
    83. The Cancer of the Bladder Risk Assessment (COBRA) score: Estimating mortality after radical cystectomy. Cancer. 2017 Dec 01; 123(23):4574-4582. Welty CJ, Sanford TH, Wright JL, Carroll PR, Cooperberg MR, Meng MV, Porten SP. PMID: 28881475.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    84. Impact of the integration of proton magnetic resonance imaging spectroscopy to PI-RADS 2 for prediction of high grade and high stage prostate cancer. Radiol Bras. 2017 Sep-Oct; 50(5):299-307. Leapman MS, Wang ZJ, Behr SC, Kurhanewicz J, Zagoria RJ, Carroll PR, Westphalen AC. PMID: 29085163.
      View in: PubMed   Mentions:
    85. Relationships between Circulating and Intraprostatic Sex Steroid Hormone Concentrations. Cancer Epidemiol Biomarkers Prev. 2017 11; 26(11):1660-1666. Cook MB, Stanczyk FZ, Wood SN, Pfeiffer RM, Hafi M, Veneroso CC, Lynch B, Falk RT, Zhou CK, Niwa S, Emanuel E, Gao YT, Hemstreet GP, Zolfghari L, Carroll PR, Manyak MJ, Sesterhann IA, Levine PH, Hsing AW. PMID: 28830872.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    86. Outcomes of men on active surveillance for low-risk prostate cancer at a safety-net hospital. Urol Oncol. 2017 11; 35(11):663.e9-663.e14. Osterberg EC, Palmer NRA, Harris CR, Murphy GP, Blaschko SD, Chu C, Allen IE, Cooperberg MR, Carroll PR, Breyer BN. PMID: 28826701.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    87. Impact of 68Ga-PSMA-11 PET on Management in Patients with Biochemically Recurrent Prostate Cancer. J Nucl Med. 2017 12; 58(12):1956-1961. Hope TA, Aggarwal R, Chee B, Tao D, Greene KL, Cooperberg MR, Feng F, Chang A, Ryan CJ, Small EJ, Carroll PR. PMID: 28522741.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    88. Community-based Outcomes of Open versus Robot-assisted Radical Prostatectomy. Eur Urol. 2018 02; 73(2):215-223. Herlemann A, Cowan JE, Carroll PR, Cooperberg MR. PMID: 28499617.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    89. AUA Policy Statement on the Use of Multiparametric Magnetic Resonance Imaging in the Diagnosis, Staging and Management of Prostate Cancer. J Urol. 2017 10; 198(4):832-838. Fulgham PF, Rukstalis DB, Turkbey IB, Rubenstein JN, Taneja S, Carroll PR, Pinto PA, Bjurlin MA, Eggener S. PMID: 28483574.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansPHPublic Health
    90. Management of intermediate-risk prostate cancer with active surveillance: never or sometimes? Curr Opin Urol. 2017 May; 27(3):231-237. Masic S, Washington SL, Carroll PR. PMID: 28234748.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    91. The Fitbit One Physical Activity Tracker in Men With Prostate Cancer: Validation Study. JMIR Cancer. 2017 Apr 18; 3(1):e5. Van Blarigan EL, Kenfield SA, Tantum L, Cadmus-Bertram LA, Carroll PR, Chan JM. PMID: 28420602.
      View in: PubMed   Mentions:
    92. Report of the Second Asian Prostate Cancer (A-CaP) Study Meeting. Prostate Int. 2017 Sep; 5(3):95-103. Kim CS, Lee JY, Chung BH, Kim WJ, Fai NC, Hakim L, Umbas R, Ong TA, Lim J, Letran JL, Chiong E, Wu TL, Lojanapiwat B, Türkeri L, Murphy DG, Gardiner RA, Moretti K, Cooperberg M, Carroll P, Mun SK, Hinotsu S, Hirao Y, Ozono S, Horie S, Onozawa M, Kitagawa Y, Kitamura T, Namiki M, Akaza H. PMID: 28828352.
      View in: PubMed   Mentions:
    93. Active Surveillance in Younger Men With Prostate Cancer. J Clin Oncol. 2017 Jun 10; 35(17):1898-1904. Leapman MS, Cowan JE, Nguyen HG, Shinohara KK, Perez N, Cooperberg MR, Catalona WJ, Carroll PR. PMID: 28346806.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    94. Interpreting Patient Reported Urinary and Sexual Function Outcomes across Multiple Validated Instruments. J Urol. 2017 09; 198(3):671-677. Vertosick EA, Vickers AJ, Cowan JE, Broering JM, Carroll PR, Cooperberg MR. PMID: 28342935.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    95. Low-risk Prostate Cancer: Identification, Management, and Outcomes. Eur Urol. 2017 08; 72(2):238-249. Moschini M, Carroll PR, Eggener SE, Epstein JI, Graefen M, Montironi R, Parker C. PMID: 28318726.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    96. Expert consensus document: Semantics in active surveillance for men with localized prostate cancer - results of a modified Delphi consensus procedure. Nat Rev Urol. 2017 May; 14(5):312-322. Bruinsma SM, Roobol MJ, Carroll PR, Klotz L, Pickles T, Moore CM, Gnanapragasam VJ, Villers A, Rannikko A, Valdagni R, Frydenberg M, Kakehi Y, Filson CP, Bangma CH. PMID: 28290462.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    97. A randomised clinical study to determine the effect of a toothpaste containing enzymes and proteins on plaque oral microbiome ecology. Sci Rep. 2017 02 27; 7:43344. Adams SE, Arnold D, Murphy B, Carroll P, Green AK, Smith AM, Marsh PD, Chen T, Marriott RE, Brading MG. PMID: 28240240.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    98. Medicine information exchange networks among healthcare professionals and prescribing in geriatric medicine wards. Br J Clin Pharmacol. 2017 06; 83(6):1185-1196. Chan B, Reeve E, Matthews S, Carroll PR, Long JC, Held F, Latt M, Naganathan V, Caplan GA, Hilmer SN. PMID: 28009444.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    99. Application of a Prognostic Gleason Grade Grouping System to Assess Distant Prostate Cancer Outcomes. Eur Urol. 2017 05; 71(5):750-759. Leapman MS, Cowan JE, Simko J, Roberge G, Stohr BA, Carroll PR, Cooperberg MR. PMID: 27940155.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    100. Tissue Sources for Accurate Measurement of Germline DNA Genotypes in Prostate Cancer Patients Treated With Radical Prostatectomy. Prostate. 2017 03; 77(4):425-434. Emami NC, Leong L, Wan E, Van Blarigan EL, Cooperberg MR, Tenggara I, Carroll PR, Chan JM, Witte JS, Simko JP. PMID: 27900799.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    101. Evaluating the Four Kallikrein Panel of the 4Kscore for Prediction of High-grade Prostate Cancer in Men in the Canary Prostate Active Surveillance Study. Eur Urol. 2017 09; 72(3):448-454. Lin DW, Newcomb LF, Brown MD, Sjoberg DD, Dong Y, Brooks JD, Carroll PR, Cooperberg M, Dash A, Ellis WJ, Fabrizio M, Gleave ME, Morgan TM, Nelson PS, Thompson IM, Wagner AA, Zheng Y. PMID: 27889277.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCTClinical Trials
    102. MUC1 Expression by Immunohistochemistry Is Associated with Adverse Pathologic Features in Prostate Cancer: A Multi-Institutional Study. PLoS One. 2016; 11(11):e0165236. Eminaga O, Wei W, Hawley SJ, Auman H, Newcomb LF, Simko J, Hurtado-Coll A, Troyer DA, Carroll PR, Gleave ME, Lin DW, Nelson PS, Thompson IM, True LD, McKenney JK, Feng Z, Fazli L, Brooks JD. PMID: 27846218.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    103. Timing of Adverse Prostate Cancer Reclassification on First Surveillance Biopsy: Results from the Canary Prostate Cancer Active Surveillance Study. J Urol. 2017 04; 197(4):1026-1033. Macleod LC, Ellis WJ, Newcomb LF, Zheng Y, Brooks JD, Carroll PR, Gleave ME, Lance RS, Nelson PS, Thompson IM, Wagner AA, Wei JT, Lin DW. PMID: 27810448.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    104. Histologic Grading of Prostatic Adenocarcinoma Can Be Further Optimized: Analysis of the Relative Prognostic Strength of Individual Architectural Patterns in 1275 Patients From the Canary Retrospective Cohort. Am J Surg Pathol. 2016 11; 40(11):1439-1456. McKenney JK, Wei W, Hawley S, Auman H, Newcomb LF, Boyer HD, Fazli L, Simko J, Hurtado-Coll A, Troyer DA, Tretiakova MS, Vakar-Lopez F, Carroll PR, Cooperberg MR, Gleave ME, Lance RS, Lin DW, Nelson PS, Thompson IM, True LD, Feng Z, Brooks JD. PMID: 27635949.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    105. Variation and Predictors of Surgical Case Costs among Urologists. Urol Pract. 2017 Jul; 4(4):277-284. Hampson LA, Odisho AY, Meng MV, Carroll PR. PMID: 30906821.
      View in: PubMed   Mentions:
    106. What is the best way not to treat prostate cancer? Urol Oncol. 2017 02; 35(2):42-50. Leapman MS, Carroll PR. PMID: 27746147.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    107. Development and validation of a 24-gene predictor of response to postoperative radiotherapy in prostate cancer: a matched, retrospective analysis. Lancet Oncol. 2016 Nov; 17(11):1612-1620. Zhao SG, Chang SL, Spratt DE, Erho N, Yu M, Ashab HA, Alshalalfa M, Speers C, Tomlins SA, Davicioni E, Dicker AP, Carroll PR, Cooperberg MR, Freedland SJ, Karnes RJ, Ross AE, Schaeffer EM, Den RB, Nguyen PL, Feng FY. PMID: 27743920.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansCells
    108. Setting an Agenda for Assessment of Health-related Quality of Life Among Men with Prostate Cancer on Active Surveillance: A Consensus Paper from a European School of Oncology Task Force. Eur Urol. 2017 02; 71(2):274-280. Villa S, Kendel F, Venderbos L, Rancati T, Bangma C, Carroll P, Denis L, Klotz L, Korfage IJ, Lane AJ, Magnani T, Mastris K, Rannikko A, Roobol M, Trock B, Van den Bergh R, Van Poppel H, Valdagni R, Bellardita L. PMID: 27720532.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    109. Correction: Endoscopic Gold Fiducial Marker Placement into the Bladder Wall to Optimize Radiotherapy Targeting for Bladder-Preserving Management of Muscle-Invasive Bladder Cancer: Feasibility and Initial Outcomes. PLoS One. 2016; 11(10):e0164558. Garcia MM, Gottschalk AR, Brajtbord J, Konety BR, Meng MV, Roach M, Carroll PR. PMID: 27711167.
      View in: PubMed   Mentions:    Fields:    
    110. Systemic GM-CSF Recruits Effector T Cells into the Tumor Microenvironment in Localized Prostate Cancer. Cancer Immunol Res. 2016 11; 4(11):948-958. Wei XX, Chan S, Kwek S, Lewis J, Dao V, Zhang L, Cooperberg MR, Ryan CJ, Lin AM, Friedlander TW, Rini B, Kane C, Simko JP, Carroll PR, Small EJ, Fong L. PMID: 27688020.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    111. A Randomized Study of Intraoperative Autologous Retropubic Urethral Sling on Urinary Control after Robotic Assisted Radical Prostatectomy. J Urol. 2017 02; 197(2):369-375. Nguyen HG, Punnen S, Cowan JE, Leapman M, Cary C, Welty C, Weinberg V, Cooperberg MR, Meng MV, Greene KL, Garcia M, Carroll PR. PMID: 27693447.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    112. 68Ga-PSMA-11 PET Imaging of Response to Androgen Receptor Inhibition: First Human Experience. J Nucl Med. 2017 Jan; 58(1):81-84. Hope TA, Truillet C, Ehman EC, Afshar-Oromieh A, Aggarwal R, Ryan CJ, Carroll PR, Small EJ, Evans MJ. PMID: 27660139.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansAnimalsCells
    113. Magnetic Resonance Imaging-Ultrasound Fusion Biopsy During Prostate Cancer Active Surveillance. Eur Urol. 2017 08; 72(2):275-281. Tran GN, Leapman MS, Nguyen HG, Cowan JE, Shinohara K, Westphalen AC, Carroll PR. PMID: 27595378.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    114. 18F Fluorocholine Dynamic Time-of-Flight PET/MR Imaging in Patients with Newly Diagnosed Intermediate- to High-Risk Prostate Cancer: Initial Clinical-Pathologic Comparisons. Radiology. 2017 Feb; 282(2):429-436. Choi JY, Yang J, Noworolski SM, Behr S, Chang AJ, Simko JP, Nguyen HG, Carroll PR, Kurhanewicz J, Seo Y. PMID: 27513849.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCTClinical Trials
    115. Validity of the Cancer of the Prostate Risk Assessment Score Derived From Targeted Biopsy: Modeling Evidence From Ultrasound Lesion-Directed Biopsy. Clin Genitourin Cancer. 2017 02; 15(1):93-99. Leapman MS, Ameli N, Shinohara K, Nguyen HG, Meng MV, Cooperberg MR, Carroll PR. PMID: 27522449.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    116. An Approach Using PSA Levels of 1.5?ng/mL as the Cutoff for Prostate Cancer Screening in Primary Care. Urology. 2016 Oct; 96:116-120. Crawford ED, Rosenberg MT, Partin AW, Cooperberg MR, Maccini M, Loeb S, Pettaway CA, Shore ND, Arangua P, Hoenemeyer J, Leveridge M, Leapman M, Pinto P, Thompson IM, Carroll P, Eastham J, Gomella L, Klein EA. PMID: 27450937.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    117. A diagnosis of prostate cancer and pursuit of active surveillance is not followed by weight loss: potential for a teachable moment. Prostate Cancer Prostatic Dis. 2016 12; 19(4):390-394. Liss MA, Schenk JM, Faino AV, Newcomb LF, Boyer H, Brooks JD, Carroll PR, Dash A, Fabrizio MD, Gleave ME, Nelson PS, Neuhouser ML, Wei JT, Zheng Y, Wright JL, Lin DW, Thompson IM. PMID: 27431498.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    118. A Novel Urine Exosome Gene Expression Assay to Predict High-grade Prostate Cancer at Initial Biopsy. JAMA Oncol. 2016 Jul 01; 2(7):882-9. McKiernan J, Donovan MJ, O'Neill V, Bentink S, Noerholm M, Belzer S, Skog J, Kattan MW, Partin A, Andriole G, Brown G, Wei JT, Thompson IM, Carroll P. PMID: 27032035.
      View in: PubMed   Mentions: 54     Fields:    Translation:HumansCells
    119. Pathological and Biochemical Outcomes among African-American and Caucasian Men with Low Risk Prostate Cancer in the SEARCH Database: Implications for Active Surveillance Candidacy. J Urol. 2016 11; 196(5):1408-1414. Leapman MS, Freedland SJ, Aronson WJ, Kane CJ, Terris MK, Walker K, Amling CL, Carroll PR, Cooperberg MR. PMID: 27352635.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    120. Reporting Magnetic Resonance Imaging in Men on Active Surveillance for Prostate Cancer: The PRECISE Recommendations-A Report of a European School of Oncology Task Force. Eur Urol. 2017 04; 71(4):648-655. Moore CM, Giganti F, Albertsen P, Allen C, Bangma C, Briganti A, Carroll P, Haider M, Kasivisvanathan V, Kirkham A, Klotz L, Ouzzane A, Padhani AR, Panebianco V, Pinto P, Puech P, Rannikko A, Renard-Penna R, Touijer K, Turkbey B, van Poppel H, Valdagni R, Walz J, Schoots I. PMID: 27349615.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    121. Loss of Expression of AZGP1 Is Associated With Worse Clinical Outcomes in a Multi-Institutional Radical Prostatectomy Cohort. Prostate. 2016 11; 76(15):1409-19. Brooks JD, Wei W, Pollack JR, West RB, Shin JH, Sunwoo JB, Hawley SJ, Auman H, Newcomb LF, Simko J, Hurtado-Coll A, Troyer DA, Carroll PR, Gleave ME, Lin DW, Nelson PS, Thompson IM, True LD, McKenney JK, Feng Z, Fazli L. PMID: 27325561.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    122. PTEN Loss as Determined by Clinical-grade Immunohistochemistry Assay Is Associated with Worse Recurrence-free Survival in Prostate Cancer. Eur Urol Focus. 2016 Jun; 2(2):180-188. Lotan TL, Wei W, Morais CL, Hawley ST, Fazli L, Hurtado-Coll A, Troyer D, McKenney JK, Simko J, Carroll PR, Gleave M, Lance R, Lin DW, Nelson PS, Thompson IM, True LD, Feng Z, Brooks JD. PMID: 27617307.
      View in: PubMed   Mentions: 10     Fields:    
    123. Analytic validation of a clinical-grade PTEN immunohistochemistry assay in prostate cancer by comparison with PTEN FISH. Mod Pathol. 2016 08; 29(8):904-14. Lotan TL, Wei W, Ludkovski O, Morais CL, Guedes LB, Jamaspishvili T, Lopez K, Hawley ST, Feng Z, Fazli L, Hurtado-Coll A, McKenney JK, Simko J, Carroll PR, Gleave M, Lin DW, Nelson PS, Thompson IM, True LD, Brooks JD, Lance R, Troyer D, Squire JA. PMID: 27174589.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    124. Quantified Clinical Risk Change as an End Point During Prostate Cancer Active Surveillance. Eur Urol. 2017 09; 72(3):329-332. Leapman MS, Ameli N, Cooperberg MR, Chu C, Hussein A, Shinohara K, Carroll PR. PMID: 27157998.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    125. Immediate androgen deprivation: for all or for some? Lancet Oncol. 2016 06; 17(6):683-684. Leapman MS, Carroll PR. PMID: 27155739.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    126. Prognostic value of Ki67 in localized prostate carcinoma: a multi-institutional study of >1000 prostatectomies. Prostate Cancer Prostatic Dis. 2016 09; 19(3):264-70. Tretiakova MS, Wei W, Boyer HD, Newcomb LF, Hawley S, Auman H, Vakar-Lopez F, McKenney JK, Fazli L, Simko J, Troyer DA, Hurtado-Coll A, Thompson IM, Carroll PR, Ellis WJ, Gleave ME, Nelson PS, Lin DW, True LD, Feng Z, Brooks JD. PMID: 27136741.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    127. NCCN Guidelines Insights: Prostate Cancer Early Detection, Version 2.2016. J Natl Compr Canc Netw. 2016 05; 14(5):509-19. Carroll PR, Parsons JK, Andriole G, Bahnson RR, Castle EP, Catalona WJ, Dahl DM, Davis JW, Epstein JI, Etzioni RB, Farrington T, Hemstreet GP, Kawachi MH, Kim S, Lange PH, Loughlin KR, Lowrance W, Maroni P, Mohler J, Morgan TM, Moses KA, Nadler RB, Poch M, Scales C, Shaneyfelt TM, Smaldone MC, Sonn G, Sprenkle P, Vickers AJ, Wake R, Shead DA, Freedman-Cass DA. PMID: 27160230.
      View in: PubMed   Mentions: 61     Fields:    Translation:Humans
    128. Serial Anatomical Prostate Ultrasound during Prostate Cancer Active Surveillance. J Urol. 2016 Sep; 196(3):727-33. Eltemamy MM, Leapman MS, Cowan JE, Westphalen A, Shinohara K, Carroll PR. PMID: 27117443.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    129. Long-term Outcomes Following Radiation Therapy For Prostate Cancer Patients With Lymph Node Metastases at Diagnosis Treated With and Without Surgery. Am J Clin Oncol. 2016 Apr; 39(2):167-72. Crehange G, Izaguirre A, Weinberg V, Hsu CC, Gottschalk AR, Hsu IC, Shinohara K, Carroll P, Roach M. PMID: 24441584.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    130. Asia prostate cancer study (A-CaP Study) launch symposium. Prostate Int. 2016 Sep; 4(3):88-96. Akaza H, Hirao Y, Kim CS, Oya M, Ozono S, Ye D, Cooperberg M, Hinotsu S, Lee JY, Zhu G, Namiki M, Horie S, Chung BH, Chen CH, Fai NC, Hakim L, Chiong E, Letran J, Umbas R, Suzuki K, Nishimura K, Ong TA, Lojanapiwat B, Wu TL, Kim WJ, Murphy D, Ogawa O, Carroll P, Naito S, Tsukamoto T. PMID: 27689065.
      View in: PubMed   Mentions:
    131. Application of a Clinical Whole-Transcriptome Assay for Staging and Prognosis of Prostate Cancer Diagnosed in Needle Core Biopsy Specimens. J Mol Diagn. 2016 05; 18(3):395-406. Knudsen BS, Kim HL, Erho N, Shin H, Alshalalfa M, Lam LLC, Tenggara I, Chadwich K, Van Der Kwast T, Fleshner N, Davicioni E, Carroll PR, Cooperberg MR, Chan JM, Simko JP. PMID: 26945428.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCells
    132. Active surveillance for prostate cancer: a narrative review of clinical guidelines. Nat Rev Urol. 2016 Mar; 13(3):151-67. Bruinsma SM, Bangma CH, Carroll PR, Leapman MS, Rannikko A, Petrides N, Weerakoon M, Bokhorst LP, Roobol MJ. PMID: 26813955.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    133. Patient-specific Meta-analysis of 2 Clinical Validation Studies to Predict Pathologic Outcomes in Prostate Cancer Using the 17-Gene Genomic Prostate Score. Urology. 2016 Mar; 89:69-75. Brand TC, Zhang N, Crager MR, Maddala T, Dee A, Sesterhenn IA, Simko JP, Cooperberg MR, Srivastava S, Rosner IL, Chan JM, Febbo PG, Carroll PR, Cullen J, Lawrence HJ. PMID: 26723180.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    134. NCCN Clinical Practice Guidelines Prostate Cancer Early Detection, Version 2.2015. J Natl Compr Canc Netw. 2015 Dec; 13(12):1534-61. Carroll PR, Parsons JK, Andriole G, Bahnson RR, Barocas DA, Castle EP, Catalona WJ, Dahl DM, Davis JW, Epstein JI, Etzioni RB, Farrington T, Hemstreet GP, Kawachi MH, Lange PH, Loughlin KR, Lowrance W, Maroni P, Mohler J, Morgan TM, Nadler RB, Poch M, Scales C, Shaneyfelt TM, Smaldone MC, Sonn G, Sprenke P, Vickers AJ, Wake R, Shead DA, Freedman-Cass D. PMID: 26656522.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansPHPublic Health
    135. Who and when should we screen for prostate cancer? Interviews with key opinion leaders. BMC Med. 2015 Nov 27; 13:288. Carlsson S, Leapman M, Carroll P, Schröder F, Albertsen PC, Ilic D, Barry M, Frosch DL, Vickers A. PMID: 26612204.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    136. Associations between circulating carotenoids, genomic instability and the risk of high-grade prostate cancer. Prostate. 2016 Mar; 76(4):339-48. Nordström T, Van Blarigan EL, Ngo V, Roy R, Weinberg V, Song X, Simko J, Carroll PR, Chan JM, Paris PL. PMID: 26585352.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    137. Cell type-specific abundance of 4EBP1 primes prostate cancer sensitivity or resistance to PI3K pathway inhibitors. Sci Signal. 2015 Nov 17; 8(403):ra116. Hsieh AC, Nguyen HG, Wen L, Edlind MP, Carroll PR, Kim W, Ruggero D. PMID: 26577921.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    138. Treatment Trends for Prostate Cancer--Reply. JAMA. 2015 Nov 10; 314(18):1977-8. Cooperberg MR, Carroll PR. PMID: 26547474.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    139. New Genetic Markers for Prostate Cancer. Urol Clin North Am. 2016 Feb; 43(1):7-15. Leapman MS, Carroll PR. PMID: 26614025.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    140. Bicycle Trauma Injuries and Hospital Admissions in the United States, 1998-2013. JAMA. 2015 Sep 01; 314(9):947-9. Sanford T, McCulloch CE, Callcut RA, Carroll PR, Breyer BN. PMID: 26325564.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    141. Outcomes of Active Surveillance for Clinically Localized Prostate Cancer in the Prospective, Multi-Institutional Canary PASS Cohort. J Urol. 2016 Feb; 195(2):313-20. Newcomb LF, Thompson IM, Boyer HD, Brooks JD, Carroll PR, Cooperberg MR, Dash A, Ellis WJ, Fazli L, Feng Z, Gleave ME, Kunju P, Lance RS, McKenney JK, Meng MV, Nicolas MM, Sanda MG, Simko J, So A, Tretiakova MS, Troyer DA, True LD, Vakar-Lopez F, Virgin J, Wagner AA, Wei JT, Zheng Y, Nelson PS, Lin DW. PMID: 26327354.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansPHPublic Health
    142. Evaluation of ERG and SPINK1 by Immunohistochemical Staining and Clinicopathological Outcomes in a Multi-Institutional Radical Prostatectomy Cohort of 1067 Patients. PLoS One. 2015; 10(7):e0132343. Brooks JD, Wei W, Hawley S, Auman H, Newcomb L, Boyer H, Fazli L, Simko J, Hurtado-Coll A, Troyer DA, Carroll PR, Gleave M, Lance R, Lin DW, Nelson PS, Thompson IM, True LD, Feng Z, McKenney JK. PMID: 26172920.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    143. Trends in Management for Patients With Localized Prostate Cancer, 1990-2013. JAMA. 2015 Jul 07; 314(1):80-2. Cooperberg MR, Carroll PR. PMID: 26151271.
      View in: PubMed   Mentions: 114     Fields:    Translation:Humans
    144. Immediate versus delayed radical prostatectomy: updated outcomes following active surveillance of prostate cancer. Eur Urol. 2015 Sep; 68(3):458-63. Filippou P, Welty CJ, Cowan JE, Perez N, Shinohara K, Carroll PR. PMID: 26138041.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    145. What is the Optimal Way to Select Candidates for Active Surveillance of Prostate Cancer? J Urol. 2015 Sep; 194(3):615-6. Dall'Era M, Carroll P. PMID: 26079332.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    146. A comparison of medical and pharmacy students' knowledge and skills of pharmacology and pharmacotherapy. Br J Clin Pharmacol. 2015 Jun; 79(6):1028-9. Hilmer SN, Seale JP, Carroll PR. PMID: 25425109.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    147. Postoperative radiation therapy for patients at high-risk of recurrence after radical prostatectomy: does timing matter? BJU Int. 2015 Nov; 116(5):713-20. Hsu CC, Paciorek AT, Cooperberg MR, Roach M, Hsu IC, Carroll PR. PMID: 25600860.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    148. Trans-Pacific variation in outcomes for men treated with primary androgen-deprivation therapy (ADT) for prostate cancer. BJU Int. 2016 Jan; 117(1):102-9. Cooperberg MR, Hinotsu S, Namiki M, Carroll PR, Akaza H. PMID: 25238114.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    149. Patterns of Local Failure following Radiation Therapy for Prostate Cancer. J Urol. 2015 Oct; 194(4):977-82. Jalloh M, Leapman MS, Cowan JE, Shinohara K, Greene KL, Roach M, Chang AJ, Chan JM, Simko JP, Carroll PR. PMID: 25983194.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    150. A multicenter study shows PTEN deletion is strongly associated with seminal vesicle involvement and extracapsular extension in localized prostate cancer. Prostate. 2015 Aug 01; 75(11):1206-15. Troyer DA, Jamaspishvili T, Wei W, Feng Z, Good J, Hawley S, Fazli L, McKenney JK, Simko J, Hurtado-Coll A, Carroll PR, Gleave M, Lance R, Lin DW, Nelson PS, Thompson IM, True LD, Brooks JD, Squire JA. PMID: 25939393.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    151. Precision Medicine in Active Surveillance for Prostate Cancer: Development of the Canary-Early Detection Research Network Active Surveillance Biopsy Risk Calculator. Eur Urol. 2015 Dec; 68(6):1083-8. Ankerst DP, Xia J, Thompson IM, Hoefler J, Newcomb LF, Brooks JD, Carroll PR, Ellis WJ, Gleave ME, Lance RS, Nelson PS, Wagner AA, Wei JT, Etzioni R, Lin DW. PMID: 25819722.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCTClinical Trials
    152. Immediate versus deferred initiation of androgen deprivation therapy in prostate cancer patients with PSA-only relapse. An observational follow-up study. Eur J Cancer. 2015 May; 51(7):817-24. Garcia-Albeniz X, Chan JM, Paciorek A, Logan RW, Kenfield SA, Cooperberg MR, Carroll PR, Hernán MA. PMID: 25794605.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    153. Impact of age on quality-of-life outcomes after treatment for localized prostate cancer. Eur Urol. 2015 Sep; 68(3):480-6. Hampson LA, Cowan JE, Zhao S, Carroll PR, Cooperberg MR. PMID: 25656807.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    154. Current Use of Imaging after Primary Treatment of Prostate Cancer. J Urol. 2015 Jul; 194(1):98-104. Hussein AA, Punnen S, Zhao S, Cowan JE, Leapman M, Tran TC, Washington SL, Truesdale MD, Carroll PR, Cooperberg MR. PMID: 25640648.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    155. Mycobacterium tuberculosis H37Rv has a single nucleotide polymorphism in PhoR which affects cell wall hydrophobicity and gene expression. Microbiology. 2015 Apr; 161(Pt 4):765-773. Schreuder LJ, Carroll P, Muwanguzi-Karugaba J, Kokoczka R, Brown AC, Parish T. PMID: 25635271.
      View in: PubMed   Mentions: 3     Fields:    Translation:Cells
    156. Untreated Gleason Grade Progression on Serial Biopsies during Prostate Cancer Active Surveillance: Clinical Course and Pathological Outcomes. J Urol. 2015 Jul; 194(1):85-90. Hussein AA, Welty CJ, Ameli N, Cowan JE, Leapman M, Porten SP, Shinohara K, Carroll PR. PMID: 25623742.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    157. Active surveillance for low-risk prostate cancer: developments to date. Eur Urol. 2015 Apr; 67(4):646-8. Bangma CH, Valdagni R, Carroll PR, van Poppel H, Klotz L, Hugosson J. PMID: 25435266.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansPHPublic Health
    158. Sustainable Measurement of Response Shift in Prostate Cancer Patients: Adjusting Health Related Quality of Life with the Then-Test. Value Health. 2014 Nov; 17(7):A651. Ten Ham RM, Wilson LS, Broering JM, Cooperberg MR, Carroll P. PMID: 27202352.
      View in: PubMed   Mentions:    Fields:    
    159. Overdetection of recurrence after radical prostatectomy: estimates based on patient and tumor characteristics. Clin Cancer Res. 2014 Oct 15; 20(20):5302-10. Xia J, Trock BJ, Gulati R, Mallinger L, Cooperberg MR, Carroll PR, Carter HB, Etzioni R. PMID: 25320374.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    160. Selenoprotein and antioxidant genes and the risk of high-grade prostate cancer and prostate cancer recurrence. Prostate. 2015 Jan; 75(1):60-9. Gerstenberger JP, Bauer SR, Van Blarigan EL, Sosa E, Song X, Witte JS, Carroll PR, Chan JM. PMID: 25284284.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    161. Extended followup and risk factors for disease reclassification in a large active surveillance cohort for localized prostate cancer. J Urol. 2015 Mar; 193(3):807-11. Welty CJ, Cowan JE, Nguyen H, Shinohara K, Perez N, Greene KL, Chan JM, Meng MV, Simko JP, Cooperberg MR, Carroll PR. PMID: 25261803.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    162. Activated lymphocyte recruitment into the tumor microenvironment following preoperative sipuleucel-T for localized prostate cancer. J Natl Cancer Inst. 2014 Nov; 106(11). Fong L, Carroll P, Weinberg V, Chan S, Lewis J, Corman J, Amling CL, Stephenson RA, Simko J, Sheikh NA, Sims RB, Frohlich MW, Small EJ. PMID: 25255802.
      View in: PubMed   Mentions: 39     Fields:    Translation:HumansCellsCTClinical Trials
    163. Long-term health-related quality of life after primary treatment for localized prostate cancer: results from the CaPSURE registry. Eur Urol. 2015 Oct; 68(4):600-8. Punnen S, Cowan JE, Chan JM, Carroll PR, Cooperberg MR. PMID: 25242555.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    164. Prostate cancer early detection, version 1.2014. Featured updates to the NCCN Guidelines. J Natl Compr Canc Netw. 2014 Sep; 12(9):1211-9; quiz 1219. Carroll PR, Parsons JK, Andriole G, Bahnson RR, Barocas DA, Catalona WJ, Dahl DM, Davis JW, Epstein JI, Etzioni RB, Giri VN, Hemstreet GP, Kawachi MH, Lange PH, Loughlin KR, Lowrance W, Maroni P, Mohler J, Morgan TM, Nadler RB, Poch M, Scales C, Shanefelt TM, Vickers AJ, Wake R, Shead DA, Ho M. PMID: 25190691.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansPHPublic Health
    165. Reply to Yuri Tolkach, Markus Kuczyk, Florian Imkamp's letter to the editor re: Eric A. Klein, Matthew R. Cooperberg, Cristina Magi-Galluzzi, et al. A 17-gene assay to predict prostate cancer aggressiveness in the context of gleason grade heterogeneity, tumor multifocality, and biopsy undersampling. Eur urol 2014;66:550-60. Eur Urol. 2014 Dec; 66(6):e117-8. Klein EA, Cooperberg MR, Carroll PR. PMID: 25150174.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    166. Seventh Joint Meeting of K-J-CaP and CaPSURE: extending the global initiative to improve prostate cancer management. Prostate Int. 2014; 2(2):50-69. Akaza H, Kim CS, Carroll P, Choi IY, Chung BH, Cooperberg MR, Hirao Y, Hinotsu S, Horie S, Lee JY, Namiki M, Ng CF, Onozawa M, Ozono S, Ueno S, Umbas R, Ye D, Zhu G. PMID: 26153555.
      View in: PubMed   Mentions:
    167. miR-19, miR-345, miR-519c-5p serum levels predict adverse pathology in prostate cancer patients eligible for active surveillance. PLoS One. 2014; 9(6):e98597. Wang SY, Shiboski S, Belair CD, Cooperberg MR, Simko JP, Stoppler H, Cowan J, Carroll PR, Blelloch R. PMID: 24893170.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    168. A 17-gene assay to predict prostate cancer aggressiveness in the context of Gleason grade heterogeneity, tumor multifocality, and biopsy undersampling. Eur Urol. 2014 Sep; 66(3):550-60. Klein EA, Cooperberg MR, Magi-Galluzzi C, Simko JP, Falzarano SM, Maddala T, Chan JM, Li J, Cowan JE, Tsiatis AC, Cherbavaz DB, Pelham RJ, Tenggara-Hunter I, Baehner FL, Knezevic D, Febbo PG, Shak S, Kattan MW, Lee M, Carroll PR. PMID: 24836057.
      View in: PubMed   Mentions: 124     Fields:    Translation:HumansCells
    169. Updated trends in imaging use in men diagnosed with prostate cancer. Prostate Cancer Prostatic Dis. 2014 Sep; 17(3):246-51. Porten SP, Smith A, Odisho AY, Litwin MS, Saigal CS, Carroll PR, Cooperberg MR. PMID: 24819235.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    170. Point/Counterpoint: early detection of prostate cancer: do the benefits outweigh the consequences? J Natl Compr Canc Netw. 2014 May; 12(5 Suppl):768-71. Carroll PR, Vickers AJ. PMID: 24853213.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    171. Evolution and immediate future of US screening guidelines. Urol Clin North Am. 2014 May; 41(2):229-35. Greene KL, Punnen S, Carroll PR. PMID: 24725485.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansPHPublic Health
    172. Meaningful end points and outcomes in men on active surveillance for early-stage prostate cancer. Curr Opin Urol. 2014 May; 24(3):288-92. Welty CJ, Cooperberg MR, Carroll PR. PMID: 24614347.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    173. Racial variation in prostate cancer upgrading and upstaging among men with low-risk clinical characteristics. Eur Urol. 2015 Mar; 67(3):451-7. Jalloh M, Myers F, Cowan JE, Carroll PR, Cooperberg MR. PMID: 24746973.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    174. Drug and device development for localized prostate cancer: report of a Food and Drug Administration/American Urological Association public workshop. Urology. 2014 May; 83(5):975-8. Jarow JP, Thompson IM, Kluetz PG, Baxley J, Sridhara R, Scardino P, Carroll P, Albertsen P, Carter HB, Brawley O, Sartor O, Sandler H, Kiefert JJ, Morton RA. PMID: 24661332.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    175. A risk-adjusted definition of biochemical recurrence after radical prostatectomy. Prostate Cancer Prostatic Dis. 2014 Jun; 17(2):174-9. Morgan TM, Meng MV, Cooperberg MR, Cowan JE, Weinberg V, Carroll PR, Lin DW. PMID: 24614692.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    176. Endoscopic gold fiducial marker placement into the bladder wall to optimize radiotherapy targeting for bladder-preserving management of muscle-invasive bladder cancer: feasibility and initial outcomes. PLoS One. 2014; 9(3):e89754. Garcia MM, Gottschalk AR, Brajtbord J, Konety BR, Meng MV, Roach M, Carroll PR. PMID: 24594774.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    177. Prevalence and impact of fall-risk-increasing drugs, polypharmacy, and drug-drug interactions in robust versus frail hospitalised falls patients: a prospective cohort study. Drugs Aging. 2014 Mar; 31(3):225-32. Bennett A, Gnjidic D, Gillett M, Carroll P, Matthews S, Johnell K, Fastbom J, Hilmer S. PMID: 24452921.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    178. A commentary on PSA velocity and doubling time for clinical decisions in prostate cancer. Urology. 2014 Mar; 83(3):592-6. Vickers AJ, Thompson IM, Klein E, Carroll PR, Scardino PT. PMID: 24581521.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    179. The ongoing need for improved risk stratification and monitoring for those on active surveillance for early stage prostate cancer. Eur Urol. 2014 Jun; 65(6):1032-3. Welty CJ, Carroll PR. PMID: 24636678.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    180. Age and baseline quality of life at radical prostatectomy--who has the most to lose? J Urol. 2014 Aug; 192(2):396-401. Brajtbord JS, Punnen S, Cowan JE, Welty CJ, Carroll PR. PMID: 24582539.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    181. Limited ability of existing nomograms to predict outcomes in men undergoing active surveillance for prostate cancer. BJU Int. 2014 Dec; 114(6b):E18-E24. Wang SY, Cowan JE, Cary KC, Chan JM, Carroll PR, Cooperberg MR. PMID: 24712895.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    182. The impact of frailty on pharmacokinetics in older people: using gentamicin population pharmacokinetic modeling to investigate changes in renal drug clearance by glomerular filtration. Eur J Clin Pharmacol. 2014 May; 70(5):549-55. Johnston C, Hilmer SN, McLachlan AJ, Matthews ST, Carroll PR, Kirkpatrick CM. PMID: 24522409.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    183. Physical activity and prostate gene expression in men with low-risk prostate cancer. Cancer Causes Control. 2014 Apr; 25(4):515-23. Magbanua MJ, Richman EL, Sosa EV, Jones LW, Simko J, Shinohara K, Haqq CM, Carroll PR, Chan JM. PMID: 24504435.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    184. Role of endorectal MR imaging and MR spectroscopic imaging in defining treatable intraprostatic tumor foci in prostate cancer: quantitative analysis of imaging contour compared to whole-mount histopathology. Radiother Oncol. 2014 Feb; 110(2):303-8. Anwar M, Westphalen AC, Jung AJ, Noworolski SM, Simko JP, Kurhanewicz J, Roach M, Carroll PR, Coakley FV. PMID: 24444524.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    185. Overdiagnosis and overtreatment of prostate cancer. Eur Urol. 2014 Jun; 65(6):1046-55. Loeb S, Bjurlin MA, Nicholson J, Tammela TL, Penson DF, Carter HB, Carroll P, Etzioni R. PMID: 24439788.
      View in: PubMed   Mentions: 123     Fields:    Translation:Humans
    186. The argument for palliative care in prostate cancer. Transl Androl Urol. 2013 Dec; 2(4):278-80. Sanford MT, Greene KL, Carroll PR. PMID: 26816740.
      View in: PubMed   Mentions:
    187. Serial prostate biopsy and risk of lower urinary tract symptoms: results from a large, single-institution active surveillance cohort. Urology. 2014 Jan; 83(1):33-8. Glass AS, Hilton JF, Cowan JE, Washington SL, Carroll PR. PMID: 24246319.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    188. Clinical utility of endorectal MRI-guided prostate biopsy: preliminary experience. J Magn Reson Imaging. 2014 Aug; 40(2):314-23. Jung AJ, Westphalen AC, Kurhanewicz J, Wang ZJ, Carroll PR, Simko JP, Coakley FV. PMID: 24924999.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCTClinical Trials
    189. Impact of androgen deprivation therapy on mental and emotional well-being in men with prostate cancer: analysis from the CaPSURE™ registry. J Urol. 2014 Apr; 191(4):964-70. Cary KC, Singla N, Cowan JE, Carroll PR, Cooperberg MR. PMID: 24184370.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    190. Temporal trends and predictors of salvage cancer treatment after failure following radical prostatectomy or radiation therapy: an analysis from the CaPSURE registry. Cancer. 2014 Feb 15; 120(4):507-12. Cary KC, Paciorek A, Fuldeore MJ, Carroll PR, Cooperberg MR. PMID: 24496867.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    191. Semiautomatic registration of digital histopathology images to in vivo MR images in molded and unmolded prostates. J Magn Reson Imaging. 2014 May; 39(5):1223-9. Starobinets O, Guo R, Simko JP, Kuchinsky K, Kurhanewicz J, Carroll PR, Greene KL, Noworolski SM. PMID: 24136783.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    192. Impact of folate intake on prostate cancer recurrence following definitive therapy: data from CaPSURE™. J Urol. 2014 Apr; 191(4):971-6. Tomaszewski JJ, Richman EL, Sadetsky N, O'Keefe DS, Carroll PR, Davies BJ, Chan JM. PMID: 24095905.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    193. Effect of comprehensive lifestyle changes on telomerase activity and telomere length in men with biopsy-proven low-risk prostate cancer: 5-year follow-up of a descriptive pilot study. Lancet Oncol. 2013 Oct; 14(11):1112-1120. Ornish D, Lin J, Chan JM, Epel E, Kemp C, Weidner G, Marlin R, Frenda SJ, Magbanua MJM, Daubenmier J, Estay I, Hills NK, Chainani-Wu N, Carroll PR, Blackburn EH. PMID: 24051140.
      View in: PubMed   Mentions: 75     Fields:    Translation:Humans
    194. Predictors of pathologic progression on biopsy among men on active surveillance for localized prostate cancer: the value of the pattern of surveillance biopsies. Eur Urol. 2014 Aug; 66(2):337-42. Cary KC, Cowan JE, Sanford M, Shinohara K, Perez N, Chan JM, Meng MV, Carroll PR. PMID: 24035632.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    195. Antioxidant and vitamin E transport genes and risk of high-grade prostate cancer and prostate cancer recurrence. Prostate. 2013 Dec; 73(16):1786-95. Bauer SR, Richman EL, Sosa E, Weinberg V, Song X, Witte JS, Carroll PR, Chan JM. PMID: 24038157.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    196. Early salvage radiotherapy following radical prostatectomy. Eur Urol. 2014 Jun; 65(6):1034-43. Pfister D, Bolla M, Briganti A, Carroll P, Cozzarini C, Joniau S, van Poppel H, Roach M, Stephenson A, Wiegel T, Zelefsky MJ. PMID: 23972524.
      View in: PubMed   Mentions: 34     Fields:    Translation:Humans
    197. Autologous retro-pubic urethral sling: a novel, quick, intra-operative technique to improve continence after robotic-assisted radical prostatectomy. J Robot Surg. 2014 Jun; 8(2):99-104. Punnen S, Clint Cary K, Glass AS, Cowan JE, Carroll PR. PMID: 27637518.
      View in: PubMed   Mentions:    Fields:    
    198. Measurement equivalence using a mixed-mode approach to administer health-related quality of life instruments. Qual Life Res. 2014 Mar; 23(2):495-508. Broering JM, Paciorek A, Carroll PR, Wilson LS, Litwin MS, Miaskowski C. PMID: 23943258.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    199. Reply to A. Azad et al. J Clin Oncol. 2013 Sep 10; 31(26):3296-7. Cooperberg MR, Cowan JE, Carroll PR. PMID: 23943835.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    200. Editorial comment. J Urol. 2013 Oct; 190(4):1223. Cary KC, Carroll PR. PMID: 23856519.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    201. A longitudinal study of anxiety, depression and distress as predictors of sexual and urinary quality of life in men with prostate cancer. BJU Int. 2013 Jul; 112(2):E67-75. Punnen S, Cowan JE, Dunn LB, Shumay DM, Carroll PR, Cooperberg MR. PMID: 23795800.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    202. Sixth joint meeting of J-CaP and CaPSURE--a multinational perspective on prostate cancer management and patient outcomes. Jpn J Clin Oncol. 2013 Jul; 43(7):756-66. Akaza H, Hinotsu S, Cooperberg MR, Chung BH, Youl Lee J, Umbas R, Tsukamoto T, Namiki M, Carroll P. PMID: 23723314.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansPHPublic Health
    203. Patient demographics, quality of life, and disease features of men with newly diagnosed prostate cancer: trends in the PSA era. Urology. 2013 Jul; 82(1):60-5. Glass AS, Cowan JE, Fuldeore MJ, Cooperberg MR, Carroll PR, Kenfield SA, Greene KL. PMID: 23706257.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    204. Endorectal MRI and MR spectroscopic imaging of prostate cancer: developing selection criteria for MR-guided focal therapy. J Magn Reson Imaging. 2014 Mar; 39(3):519-25. Chang ST, Westphalen AC, Jha P, Jung AJ, Carroll PR, Kurhanewicz J, Coakley FV. PMID: 23681669.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    205. Multi-institutional validation of the CAPRA-S score to predict disease recurrence and mortality after radical prostatectomy. Eur Urol. 2014 Jun; 65(6):1171-7. Punnen S, Freedland SJ, Presti JC, Aronson WJ, Terris MK, Kane CJ, Amling CL, Carroll PR, Cooperberg MR. PMID: 23587869.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    206. Benign prostate glandular tissue at radical prostatectomy surgical margins. Urology. 2013 Jul; 82(1):154-9. Odisho AY, Washington SL, Meng MV, Cowan JE, Simko JP, Carroll PR. PMID: 23522995.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    207. Urinary TMPRSS2:ERG and PCA3 in an active surveillance cohort: results from a baseline analysis in the Canary Prostate Active Surveillance Study. Clin Cancer Res. 2013 May 01; 19(9):2442-50. Lin DW, Newcomb LF, Brown EC, Brooks JD, Carroll PR, Feng Z, Gleave ME, Lance RS, Sanda MG, Thompson IM, Wei JT, Nelson PS. PMID: 23515404.
      View in: PubMed   Mentions: 43     Fields:    Translation:Humans
    208. How does robot-assisted radical prostatectomy (RARP) compare with open surgery in men with high-risk prostate cancer? BJU Int. 2013 Aug; 112(4):E314-20. Punnen S, Meng MV, Cooperberg MR, Greene KL, Cowan JE, Carroll PR. PMID: 23451984.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    209. Validation of a cell-cycle progression gene panel to improve risk stratification in a contemporary prostatectomy cohort. J Clin Oncol. 2013 Apr 10; 31(11):1428-34. Cooperberg MR, Simko JP, Cowan JE, Reid JE, Djalilvand A, Bhatnagar S, Gutin A, Lanchbury JS, Swanson GP, Stone S, Carroll PR. PMID: 23460710.
      View in: PubMed   Mentions: 87     Fields:    Translation:Humans
    210. Men with low preoperative sexual function may benefit from nerve sparing radical prostatectomy. J Urol. 2013 Sep; 190(3):981-6. Harris CR, Punnen S, Carroll PR. PMID: 23410984.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    211. Active surveillance: does serial prostate biopsy increase histological inflammation? Prostate Cancer Prostatic Dis. 2013 Jun; 16(2):165-9. Glass AS, Porten SP, Bonham M, Tran TC, Cowan JE, Punnen S, Chan JM, Carroll PR. PMID: 23318528.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    212. Focal therapy: a new active surveillance tool? Oncology (Williston Park). 2013 Jan 15; 27(1). Glass AS, Carroll PR. PMID: 25188237.
      View in: PubMed   Mentions:    Fields:    
    213. A model for the design and construction of a resource for the validation of prognostic prostate cancer biomarkers: the Canary Prostate Cancer Tissue Microarray. Adv Anat Pathol. 2013 Jan; 20(1):39-44. Hawley S, Fazli L, McKenney JK, Simko J, Troyer D, Nicolas M, Newcomb LF, Cowan JE, Crouch L, Ferrari M, Hernandez J, Hurtado-Coll A, Kuchinsky K, Liew J, Mendez-Meza R, Smith E, Tenggara I, Zhang X, Carroll PR, Chan JM, Gleave M, Lance R, Lin DW, Nelson PS, Thompson IM, Feng Z, True LD, Brooks JD. PMID: 23232570.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    214. Prostate specific antigen best practice statement: 2009 update. J Urol. 2013 Jan; 189(1 Suppl):S2-S11. Greene KL, Albertsen PC, Babaian RJ, Carter HB, Gann PH, Han M, Kuban DA, Sartor AO, Stanford JL, Zietman A, Carroll P. PMID: 23234625.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    215. Role of active surveillance in the management of localized prostate cancer. J Natl Cancer Inst Monogr. 2012 Dec; 2012(45):202-6. Glass AS, Cooperberg MR, Meng MV, Carroll PR. PMID: 23271774.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    216. Salvage therapies after radiation therapy. Urol Oncol. 2012 Nov-Dec; 30(6):940-1. Eastham JA, Carroll P, Pisters L, Nguyen PT, Touijer K. PMID: 23218071.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    217. Prostate cancer mortality following active surveillance versus immediate radical prostatectomy. Clin Cancer Res. 2012 Oct 01; 18(19):5471-8. Xia J, Trock BJ, Cooperberg MR, Gulati R, Zeliadt SB, Gore JL, Lin DW, Carroll PR, Carter HB, Etzioni R. PMID: 23008476.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    218. Factors associated with satisfaction with prostate cancer care: results from Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE). BJU Int. 2013 Feb; 111(2):213-20. Resnick MJ, Guzzo TJ, Cowan JE, Knight SJ, Carroll PR, Penson DF. PMID: 22928860.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    219. Aspirin use and the risk of prostate cancer mortality in men treated with prostatectomy or radiotherapy. J Clin Oncol. 2012 Oct 01; 30(28):3540-4. Choe KS, Cowan JE, Chan JM, Carroll PR, D'Amico AV, Liauw SL. PMID: 22927523.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    220. Reply to Jai Prakash, Apul Goel and Manish Garg's Letter to the Editor re: Anobel Y. Odisho, Anna B. Berry, Ardalan E. Ahmad, Matthew R. Cooperberg, Peter R. Carroll, Badrinath R. Konety. Reflex ImmunoCyt Testing for the Diagnosis of Bladder Cancer in Patients with Atypical Urine Cytology. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2012.04.019. Eur Urol. 2012 Nov; 62(5):e88. Odisho AY, Berry AB, Ahmad AE, Cooperberg MR, Carroll PR, Konety BR. PMID: 22921716.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    221. The impact of serial prostate biopsies on sexual function in men on active surveillance for prostate cancer. J Urol. 2012 Oct; 188(4):1252-8. Hilton JF, Blaschko SD, Whitson JM, Cowan JE, Carroll PR. PMID: 22902015.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    222. Gender differences in academic productivity and academic career choice among urology residents. J Urol. 2012 Oct; 188(4):1286-90. Yang G, Villalta JD, Weiss DA, Carroll PR, Breyer BN. PMID: 22902027.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    223. Active surveillance for low-risk prostate cancer. Crit Rev Oncol Hematol. 2013 Mar; 85(3):295-302. Bangma CH, Bul M, van der Kwast TH, Pickles T, Korfage IJ, Hoeks CM, Steyerberg EW, Jenster G, Kattan MW, Bellardita L, Carroll PR, Denis LJ, Parker C, Roobol MJ, Emberton M, Klotz LH, Rannikko A, Kakehi Y, Lane JA, Schröder FH, Semjonow A, Trock BJ, Valdagni R. PMID: 22878262.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansPHPublic Health
    224. The effect of behavioural risk factors on osteoporosis in Irish women. Ir J Med Sci. 2013 Mar; 182(1):97-105. Cummins NM, Jakeman PM, Sestak I, Murphy N, Carroll P. PMID: 22843417.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    225. Early detection of prostate cancer: more information, more clarity. Eur Urol. 2012 Nov; 62(5):753-5; discussion 755-6. Glass AS, Cooperberg MR, Carroll PR. PMID: 22766168.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    226. Evaluating prostate cancer mortality and competing risks of death in patients with localized prostate cancer using a comprehensive nomogram. Prostate Cancer Prostatic Dis. 2012 Dec; 15(4):374-9. Kutikov A, Cooperberg MR, Paciorek AT, Uzzo RG, Carroll PR, Boorjian SA. PMID: 22710832.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    227. Local staging of prostate cancer: comparative accuracy of T2-weighted endorectal MR imaging and transrectal ultrasound. Clin Imaging. 2012 Sep-Oct; 36(5):547-52. Jung AJ, Coakley FV, Shinohara K, Carroll PR, Kurhanewicz J, Cowan JE, Westphalen AC. PMID: 22920360.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    228. Active surveillance for prostate cancer: a systematic review of the literature. Eur Urol. 2012 Dec; 62(6):976-83. Dall'Era MA, Albertsen PC, Bangma C, Carroll PR, Carter HB, Cooperberg MR, Freedland SJ, Klotz LH, Parker C, Soloway MS. PMID: 22698574.
      View in: PubMed   Mentions: 132     Fields:    Translation:Humans
    229. Best practices in robot-assisted radical prostatectomy: recommendations of the Pasadena Consensus Panel. Eur Urol. 2012 Sep; 62(3):368-81. Montorsi F, Wilson TG, Rosen RC, Ahlering TE, Artibani W, Carroll PR, Costello A, Eastham JA, Ficarra V, Guazzoni G, Menon M, Novara G, Patel VR, Stolzenburg JU, Van der Poel H, Van Poppel H, Mottrie A. PMID: 22763081.
      View in: PubMed   Mentions: 37     Fields:    Translation:Humans
    230. The quantitative Gleason score improves prostate cancer risk assessment. Cancer. 2012 Dec 15; 118(24):6046-54. Reese AC, Cowan JE, Brajtbord JS, Harris CR, Carroll PR, Cooperberg MR. PMID: 22674220.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    231. Systematic review and meta-analysis of studies reporting oncologic outcome after robot-assisted radical prostatectomy. Eur Urol. 2012 Sep; 62(3):382-404. Novara G, Ficarra V, Mocellin S, Ahlering TE, Carroll PR, Graefen M, Guazzoni G, Menon M, Patel VR, Shariat SF, Tewari AK, Van Poppel H, Zattoni F, Montorsi F, Mottrie A, Rosen RC, Wilson TG. PMID: 22749851.
      View in: PubMed   Mentions: 75     Fields:    Translation:Humans
    232. Systematic review and meta-analysis of studies reporting urinary continence recovery after robot-assisted radical prostatectomy. Eur Urol. 2012 Sep; 62(3):405-17. Ficarra V, Novara G, Rosen RC, Artibani W, Carroll PR, Costello A, Menon M, Montorsi F, Patel VR, Stolzenburg JU, Van der Poel H, Wilson TG, Zattoni F, Mottrie A. PMID: 22749852.
      View in: PubMed   Mentions: 135     Fields:    Translation:Humans
    233. Regional cell proliferation in microdissected human prostate specimens after heavy water labeling in vivo: correlation with prostate epithelial cells isolated from seminal fluid. Clin Cancer Res. 2012 Jun 15; 18(12):3250-60. Hayes GM, Simko J, Holochwost D, Kuchinsky K, Busch R, Misell L, Murphy EJ, Carroll P, Chan J, Shinohara K, Hellerstein MK. PMID: 22553345.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    234. Characteristics of older and younger patients with suspected paracetamol toxicity. Australas J Ageing. 2012 Sep; 31(3):190-3. Kane A, Mitchell SJ, Carroll PR, Matthews S, Hilmer SN. PMID: 22950592.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    235. Reflex ImmunoCyt testing for the diagnosis of bladder cancer in patients with atypical urine cytology. Eur Urol. 2013 May; 63(5):936-40. Odisho AY, Berry AB, Ahmad AE, Cooperberg MR, Carroll PR, Konety BR. PMID: 22521093.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    236. Ten-year follow-up of neoadjuvant therapy with goserelin acetate and flutamide before radical prostatectomy for clinical T3 and T4 prostate cancer: update on Southwest Oncology Group Study 9109. Urology. 2012 Mar; 79(3):633-7. Berglund RK, Tangen CM, Powell IJ, Lowe BA, Haas GP, Carroll PR, Canby-Hagino ED, deVere White R, Hemstreet GP, Crawford ED, Thompson IM, Klein EA. PMID: 22386416.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCTClinical Trials
    237. Proton beam therapy and treatment for localized prostate cancer: if you build it, they will come. Arch Intern Med. 2012 Feb 13; 172(3):280-3. Aaronson DS, Odisho AY, Hills N, Cress R, Carroll PR, Dudley RA, Cooperberg MR. PMID: 22332166.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    238. Does local recurrence of prostate cancer after radiation therapy occur at the site of primary tumor? Results of a longitudinal MRI and MRSI study. Int J Radiat Oncol Biol Phys. 2012 Apr 01; 82(5):e787-93. Arrayeh E, Westphalen AC, Kurhanewicz J, Roach M, Jung AJ, Carroll PR, Coakley FV. PMID: 22331003.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    239. Fifth Joint Meeting of J-CaP and CaPSURE: advancing the global understanding of prostate cancer and its management. Jpn J Clin Oncol. 2012 Mar; 42(3):226-36. Akaza H, Carroll P, Cooperberg MR, Hinotsu S. PMID: 22217576.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    240. Outcomes for radical prostatectomy: is it the singer, the song, or both? J Clin Oncol. 2012 Feb 10; 30(5):476-8. Cooperberg MR, Odisho AY, Carroll PR. PMID: 22215744.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    241. The Society of Urologic Oncology's reply to the US Preventative Services Task Force's recommendation on PSA testing. Urol Oncol. 2012 Jan-Feb; 30(1):117-9. Messing EM, Albertsen P, Andriole GL, Carroll PR, Klein EA. PMID: 22243597.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansPHPublic Health
    242. Endorectal MRI of prostate cancer: incremental prognostic importance of gross locally advanced disease. AJR Am J Roentgenol. 2011 Dec; 197(6):1369-74. Muglia VF, Westphalen AC, Wang ZJ, Kurhanewicz J, Carroll PR, Coakley FV. PMID: 22109291.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    243. PSA screening: determinants of primary-care physician practice patterns. Prostate Cancer Prostatic Dis. 2012 Jun; 15(2):189-94. Tasian GE, Cooperberg MR, Potter MB, Cowan JE, Greene KL, Carroll PR, Chan JM. PMID: 22343837.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansPHPublic Health
    244. Transrectal ultrasonography-guided biopsy does not reliably identify dominant cancer location in men with low-risk prostate cancer. BJU Int. 2012 Jul; 110(1):50-5. Washington SL, Bonham M, Whitson JM, Cowan JE, Carroll PR. PMID: 22077660.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    245. Poor agreement of prostate specific antigen doubling times calculated using ultrasensitive versus standard prostate specific antigen values: important impact on risk assessment. J Urol. 2011 Dec; 186(6):2228-32. Reese AC, Fradet V, Whitson JM, Davis CB, Carroll PR. PMID: 22014796.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    246. Among potent men post radical prostatectomy, does the need for phosphodiesterase inhibitors have an impact on sexual bother scores? BJU Int. 2012 May; 109(10):1520-4. Punnen S, Cooperberg MR, Sadetsky N, Carroll PR. PMID: 21999368.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    247. Changes in cancer volume in serial biopsies of men on active surveillance for early stage prostate cancer. J Urol. 2011 Nov; 186(5):1825-9. Porten SP, Whitson JM, Cowan JE, Perez N, Shinohara K, Carroll PR. PMID: 21944082.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    248. Prediction of erectile function following treatment for prostate cancer. JAMA. 2011 Sep 21; 306(11):1205-14. Alemozaffar M, Regan MM, Cooperberg MR, Wei JT, Michalski JM, Sandler HM, Hembroff L, Sadetsky N, Saigal CS, Litwin MS, Klein E, Kibel AS, Hamstra DA, Pisters LL, Kuban DA, Kaplan ID, Wood DP, Ciezki J, Dunn RL, Carroll PR, Sanda MG. PMID: 21934053.
      View in: PubMed   Mentions: 64     Fields:    Translation:HumansPHPublic Health
    249. Gene expression and biological pathways in tissue of men with prostate cancer in a randomized clinical trial of lycopene and fish oil supplementation. PLoS One. 2011; 6(9):e24004. Magbanua MJ, Roy R, Sosa EV, Weinberg V, Federman S, Mattie MD, Hughes-Fulford M, Simko J, Shinohara K, Haqq CM, Carroll PR, Chan JM. PMID: 21912659.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    250. Vegetable and fruit intake after diagnosis and risk of prostate cancer progression. Int J Cancer. 2012 Jul 01; 131(1):201-10. Richman EL, Carroll PR, Chan JM. PMID: 21823116.
      View in: PubMed   Mentions: 28     Fields:    Translation:HumansAnimals
    251. Androgen deprivation therapy and cardiovascular risk. J Clin Oncol. 2011 Sep 10; 29(26):3510-6. Punnen S, Cooperberg MR, Sadetsky N, Carroll PR. PMID: 21844498.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    252. Active surveillance for prostate cancer: progress and promise. J Clin Oncol. 2011 Sep 20; 29(27):3669-76. Cooperberg MR, Carroll PR, Klotz L. PMID: 21825257.
      View in: PubMed   Mentions: 90     Fields:    Translation:HumansPHPublic Health
    253. Treatment trends for stage I renal cell carcinoma. J Urol. 2011 Aug; 186(2):394-9. Cooperberg MR, Mallin K, Kane CJ, Carroll PR. PMID: 21679982.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    254. The potential impact of reproducibility of Gleason grading in men with early stage prostate cancer managed by active surveillance: a multi-institutional study. J Urol. 2011 Aug; 186(2):465-9. McKenney JK, Simko J, Bonham M, True LD, Troyer D, Hawley S, Newcomb LF, Fazli L, Kunju LP, Nicolas MM, Vakar-Lopez F, Zhang X, Carroll PR, Brooks JD. PMID: 21679996.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansPHPublic Health
    255. The CAPRA-S score: A straightforward tool for improved prediction of outcomes after radical prostatectomy. Cancer. 2011 Nov 15; 117(22):5039-46. Cooperberg MR, Hilton JF, Carroll PR. PMID: 21647869.
      View in: PubMed   Mentions: 65     Fields:    Translation:Humans
    256. Changes in prostate cancer grade on serial biopsy in men undergoing active surveillance. J Clin Oncol. 2011 Jul 10; 29(20):2795-800. Porten SP, Whitson JM, Cowan JE, Cooperberg MR, Shinohara K, Perez N, Greene KL, Meng MV, Carroll PR. PMID: 21632511.
      View in: PubMed   Mentions: 52     Fields:    Translation:Humans
    257. Physical activity after diagnosis and risk of prostate cancer progression: data from the cancer of the prostate strategic urologic research endeavor. Cancer Res. 2011 Jun 01; 71(11):3889-95. Richman EL, Kenfield SA, Stampfer MJ, Paciorek A, Carroll PR, Chan JM. PMID: 21610110.
      View in: PubMed   Mentions: 58     Fields:    Translation:Humans
    258. The contemporary concept of significant versus insignificant prostate cancer. Eur Urol. 2011 Aug; 60(2):291-303. Ploussard G, Epstein JI, Montironi R, Carroll PR, Wirth M, Grimm MO, Bjartell AS, Montorsi F, Freedland SJ, Erbersdobler A, van der Kwast TH. PMID: 21601982.
      View in: PubMed   Mentions: 81     Fields:    Translation:Humans
    259. Factors associated with downgrading in patients with high grade prostate cancer. Urol Oncol. 2013 May; 31(4):442-7. Whitson JM, Porten SP, Cowan JE, Simko JP, Cooperberg MR, Carroll PR. PMID: 21478037.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    260. Surgical management after active surveillance for low-risk prostate cancer: pathological outcomes compared with men undergoing immediate treatment. BJU Int. 2011 Apr; 107(8):1232-7. Dall'Era MA, Cowan JE, Simko J, Shinohara K, Davies B, Konety BR, Meng MV, Perez N, Greene K, Carroll PR. PMID: 20804478.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    261. Editorial comment. Urology. 2011 Apr; 77(4):984-5. Carroll PR, Whitson JM. PMID: 21477729.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    262. The relationship between prostate specific antigen change and biopsy progression in patients on active surveillance for prostate cancer. J Urol. 2011 May; 185(5):1656-60. Whitson JM, Porten SP, Hilton JF, Cowan JE, Perez N, Cooperberg MR, Greene KL, Meng MV, Simko JP, Shinohara K, Carroll PR. PMID: 21419438.
      View in: PubMed   Mentions: 32     Fields:    Translation:HumansPHPublic Health
    263. Transitional cell carcinoma of the bladder: racial and gender disparities in survival (1993 to 2002), stage and grade (1993 to 2007). J Urol. 2011 May; 185(5):1631-6. Mallin K, David KA, Carroll PR, Milowsky MI, Nanus DM. PMID: 21419456.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    264. Impact of androgen deprivation on physical well-being in patients with prostate cancer: analysis from the CaPSURE (Cancer of the Prostate Strategic Urologic Research Endeavor) registry. Cancer. 2011 Oct 01; 117(19):4406-13. Sadetsky N, Greene K, Cooperberg MR, Hubbard A, Carroll PR, Satariano W. PMID: 21412760.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    265. The example of CaPSURE: lessons learned from a national disease registry. World J Urol. 2011 Jun; 29(3):265-71. Porten SP, Cooperberg MR, Konety BR, Carroll PR. PMID: 21347810.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    266. Prostate cancer: reducing overtreatment: active surveillance in low-risk disease. Nat Rev Urol. 2011 Mar; 8(3):124-5. Whitson JM, Porten SP, Carroll PR. PMID: 21304508.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansPHPublic Health
    267. The needs for men undergoing active surveillance (AS) for prostate cancer: results of a focus group study. J Clin Nurs. 2011 Feb; 20(3-4):581-6. Kazer MW, Bailey DE, Colberg J, Kelly WK, Carroll P. PMID: 21219530.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansPHPublic Health
    268. Gentamicin pharmacokinetics in old age and frailty. Br J Clin Pharmacol. 2011 Feb; 71(2):224-31. Hilmer SN, Tran K, Rubie P, Wright J, Gnjidic D, Mitchell SJ, Matthews S, Carroll PR. PMID: 21219402.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    269. Oncological and functional outcomes of radical cystectomy and orthotopic bladder replacement in women. Urology. 2011 Apr; 77(4):878-83. Yang G, Whitson JM, Breyer BN, Konety BR, Carroll PR. PMID: 21215428.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    270. Serum prostate-specific antigen for the early detection of prostate cancer: always, never, or only sometimes? J Clin Oncol. 2011 Feb 01; 29(4):345-7. Carroll PR, Whitson JM, Cooperberg MR. PMID: 21189396.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansPHPublic Health
    271. Urology resident publication output and its relationship to future academic achievement. J Urol. 2011 Feb; 185(2):642-6. Yang G, Zaid UB, Erickson BA, Blaschko SD, Carroll PR, Breyer BN. PMID: 21168863.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    272. Impact of age at diagnosis on prostate cancer treatment and survival. J Clin Oncol. 2011 Jan 10; 29(2):235-41. Bechis SK, Carroll PR, Cooperberg MR. PMID: 21135285.
      View in: PubMed   Mentions: 70     Fields:    Translation:Humans
    273. Incidence of bladder neck contracture after robot-assisted laparoscopic and open radical prostatectomy. BJU Int. 2010 Dec; 106(11):1734-8. Breyer BN, Davis CB, Cowan JE, Kane CJ, Carroll PR. PMID: 20438567.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    274. Outcomes of active surveillance for men with intermediate-risk prostate cancer. J Clin Oncol. 2011 Jan 10; 29(2):228-34. Cooperberg MR, Cowan JE, Hilton JF, Reese AC, Zaid HB, Porten SP, Shinohara K, Meng MV, Greene KL, Carroll PR. PMID: 21115873.
      View in: PubMed   Mentions: 67     Fields:    Translation:Humans
    275. Microfluidic-based multiplex qRT-PCR identifies diagnostic and prognostic microRNA signatures in the sera of prostate cancer patients. Cancer Res. 2011 Jan 15; 71(2):550-60. Moltzahn F, Olshen AB, Baehner L, Peek A, Fong L, Stöppler H, Simko J, Hilton JF, Carroll P, Blelloch R. PMID: 21098088.
      View in: PubMed   Mentions: 98     Fields:    Translation:Humans
    276. Inaccuracies in assignment of clinical stage for localized prostate cancer. Cancer. 2011 Jan 15; 117(2):283-9. Reese AC, Sadetsky N, Carroll PR, Cooperberg MR. PMID: 21210472.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    277. Nutritional supplements, COX-2 and IGF-1 expression in men on active surveillance for prostate cancer. Cancer Causes Control. 2011 Jan; 22(1):141-50. Chan JM, Weinberg V, Magbanua MJ, Sosa E, Simko J, Shinohara K, Federman S, Mattie M, Hughes-Fulford M, Haqq C, Carroll PR. PMID: 21103921.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    278. Comparative risk-adjusted mortality outcomes after primary surgery, radiotherapy, or androgen-deprivation therapy for localized prostate cancer. Cancer. 2010 Nov 15; 116(22):5226-34. Cooperberg MR, Vickers AJ, Broering JM, Carroll PR. PMID: 20690197.
      View in: PubMed   Mentions: 83     Fields:    Translation:Humans
    279. Disproportionate presentation of high risk prostate cancer in a safety net health system. J Urol. 2010 Nov; 184(5):1931-6. Porten SP, Richardson DA, Odisho AY, McAninch JW, Carroll PR, Cooperberg MR. PMID: 20846693.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    280. Association of statin and nonsteroidal anti-inflammatory drug use with prostate cancer outcomes: results from CaPSURE. BJU Int. 2010 Sep; 106(5):627-32. Katz MS, Carroll PR, Cowan JE, Chan JM, D'Amico AV. PMID: 20151961.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    281. Prostate specific antigen screening for prostate cancer: knowledge of, attitudes towards, and utilization among primary care physicians. Urol Oncol. 2012 Mar-Apr; 30(2):155-60. Tasian GE, Cooperberg MR, Cowan JE, Keyashian K, Greene KL, Daniels NA, Carroll PR, Chan JM. PMID: 20800514.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansPHPublic Health
    282. Electronic patient self-assessment and management (SAM): a novel framework for cancer survivorship. BMC Med Inform Decis Mak. 2010 Jun 17; 10:34. Vickers AJ, Salz T, Basch E, Cooperberg MR, Carroll PR, Tighe F, Eastham J, Rosen RC. PMID: 20565745.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    283. Prostate cancer managed with active surveillance: role of anatomic MR imaging and MR spectroscopic imaging. Radiology. 2010 Jul; 256(1):176-83. Fradet V, Kurhanewicz J, Cowan JE, Karl A, Coakley FV, Shinohara K, Carroll PR. PMID: 20505068.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansPHPublic Health
    284. Minimal impact of clinical stage on prostate cancer prognosis among contemporary patients with clinically localized disease. J Urol. 2010 Jul; 184(1):114-9. Reese AC, Cooperberg MR, Carroll PR. PMID: 20478578.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    285. Active surveillance for early-stage prostate cancer: defining the triggers for intervention. J Clin Oncol. 2010 Jun 10; 28(17):2807-9. Whitson JM, Carroll PR. PMID: 20439633.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansPHPublic Health
    286. Increased risk of high-grade prostate cancer among infertile men. Cancer. 2010 May 01; 116(9):2140-7. Walsh TJ, Schembri M, Turek PJ, Chan JM, Carroll PR, Smith JF, Eisenberg ML, Van Den Eeden SK, Croughan MS. PMID: 20309846.
      View in: PubMed   Mentions: 31     Fields:    Translation:Humans
    287. Urologist density and county-level urologic cancer mortality. J Clin Oncol. 2010 May 20; 28(15):2499-504. Odisho AY, Cooperberg MR, Fradet V, Ahmad AE, Carroll PR. PMID: 20406931.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    288. Effect of a minimum lymph node policy in radical cystectomy and pelvic lymphadenectomy on lymph node yields, lymph node positivity rates, lymph node density, and survivorship in patients with bladder cancer. Cancer. 2010 Apr 15; 116(8):1901-8. Fang AC, Ahmad AE, Whitson JM, Ferrell LD, Carroll PR, Konety BR. PMID: 20186823.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    289. The 'CaP Calculator': an online decision support tool for clinically localized prostate cancer. BJU Int. 2010 May; 105(10):1417-22. Katz MS, Efstathiou JA, D'Amico AV, Kattan MW, Sanda MG, Nguyen PL, Smith MR, Carroll PR, Zietman AL. PMID: 20346051.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    290. Metabolic syndrome, central obesity and insulin resistance are associated with adverse pathological features in postmenopausal breast cancer. Clin Oncol (R Coll Radiol). 2010 May; 22(4):281-8. Healy LA, Ryan AM, Carroll P, Ennis D, Crowley V, Boyle T, Kennedy MJ, Connolly E, Reynolds JV. PMID: 20189371.
      View in: PubMed   Mentions: 37     Fields:    Translation:Humans
    291. Changes in specific domains of sexual function and sexual bother after radical prostatectomy. BJU Int. 2010 Oct; 106(7):1022-9. Le JD, Cooperberg MR, Sadetsky N, Hittelman AB, Meng MV, Cowan JE, Latini DM, Carroll PR. PMID: 20184571.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    292. Time trends and local variation in primary treatment of localized prostate cancer. J Clin Oncol. 2010 Mar 01; 28(7):1117-23. Cooperberg MR, Broering JM, Carroll PR. PMID: 20124165.
      View in: PubMed   Mentions: 279     Fields:    Translation:Humans
    293. NCCN clinical practice guidelines in oncology: prostate cancer early detection. J Natl Compr Canc Netw. 2010 Feb; 8(2):240-62. Kawachi MH, Bahnson RR, Barry M, Busby JE, Carroll PR, Carter HB, Catalona WJ, Cookson MS, Epstein JI, Etzioni RB, Giri VN, Hemstreet GP, Howe RJ, Lange PH, Lilja H, Loughlin KR, Mohler J, Moul J, Nadler RB, Patterson SG, Presti JC, Stroup AM, Wake R, Wei JT. PMID: 20141680.
      View in: PubMed   Mentions: 53     Fields:    Translation:Humans
    294. Impact of ethnicity on primary treatment choice and mortality in men with prostate cancer: data from CaPSURE. J Clin Oncol. 2010 Feb 20; 28(6):1069-74. Moses KA, Paciorek AT, Penson DF, Carroll PR, Master VA. PMID: 20100957.
      View in: PubMed   Mentions: 33     Fields:    Translation:Humans
    295. Eligibility for active surveillance and pathological outcomes for men undergoing radical prostatectomy in a large, community based cohort. J Urol. 2010 Jan; 183(1):138-43. Smaldone MC, Cowan JE, Carroll PR, Davies BJ. PMID: 19913808.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansPHPublic Health
    296. The impact of male circumcision on HIV transmission. J Urol. 2010 Jan; 183(1):21-6. Doyle SM, Kahn JG, Hosang N, Carroll PR. PMID: 19913816.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    297. Intakes of meat, fish, poultry, and eggs and risk of prostate cancer progression. Am J Clin Nutr. 2010 Mar; 91(3):712-21. Richman EL, Stampfer MJ, Paciorek A, Broering JM, Carroll PR, Chan JM. PMID: 20042525.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansAnimals
    298. Metabolic, pathologic, and genetic analysis of prostate tissues: quantitative evaluation of histopathologic and mRNA integrity after HR-MAS spectroscopy. NMR Biomed. 2010 May; 23(4):391-8. Santos CF, Kurhanewicz J, Tabatabai ZL, Simko JP, Keshari KR, Gbegnon A, Santos RD, Federman S, Shinohara K, Carroll PR, Haqq CM, Swanson MG. PMID: 20033906.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCells
    299. A group of genome-based biomarkers that add to a Kattan nomogram for predicting progression in men with high-risk prostate cancer. Clin Cancer Res. 2010 Jan 01; 16(1):195-202. Paris PL, Weinberg V, Albo G, Roy R, Burke C, Simko J, Carroll P, Collins C. PMID: 20028763.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    300. Editorial comment. J Urol. 2010 Feb; 183(2):564. Carroll PR. PMID: 20018313.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    301. Association of age and response to androgen-deprivation therapy with or without radiotherapy for prostate cancer: data from CaPSURE. BJU Int. 2010 Apr; 105(7):951-5. Aaronson D, Cowan J, Carroll P, Konety B. PMID: 19889066.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    302. The adjunctive use of power Doppler imaging in the preoperative assessment of prostate cancer. BJU Int. 2010 May; 105(9):1237-41. Eisenberg ML, Cowan JE, Carroll PR, Shinohara K. PMID: 19888980.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    303. UroVysion testing can lead to early identification of intravesical therapy failure in patients with high risk non-muscle invasive bladder cancer. Int Braz J Urol. 2009 Nov-Dec; 35(6):664-70; discussion 671-2. Whitson JM, Berry AB, Carroll PR, Konety BR. PMID: 20028572.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    304. Patient decision aids for prostate cancer treatment: a systematic review of the literature. CA Cancer J Clin. 2009 Nov-Dec; 59(6):379-90. Lin GA, Aaronson DS, Knight SJ, Carroll PR, Dudley RA. PMID: 19841280.
      View in: PubMed   Mentions: 41     Fields:    Translation:Humans
    305. Predictors of clinical metastasis in prostate cancer patients receiving androgen deprivation therapy: results from CaPSURE. Cancer. 2009 Oct 01; 115(19):4470-6. Abouassaly R, Paciorek A, Ryan CJ, Carroll PR, Klein EA. PMID: 19637339.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    306. Prostate specific antigen best practice statement: 2009 update. J Urol. 2009 Nov; 182(5):2232-41. Greene KL, Albertsen PC, Babaian RJ, Carter HB, Gann PH, Han M, Kuban DA, Sartor AO, Stanford JL, Zietman A, Carroll P. PMID: 19781717.
      View in: PubMed   Mentions: 105     Fields:    Translation:Humans
    307. Measuring illness uncertainty in men undergoing active surveillance for prostate cancer. Appl Nurs Res. 2011 Nov; 24(4):193-9. Bailey DE, Wallace M, Latini DM, Hegarty J, Carroll PR, Klein EA, Albertsen PC. PMID: 20974073.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansPHPublic Health
    308. Canary Prostate Active Surveillance Study: design of a multi-institutional active surveillance cohort and biorepository. Urology. 2010 Feb; 75(2):407-13. Newcomb LF, Brooks JD, Carroll PR, Feng Z, Gleave ME, Nelson PS, Thompson IM, Lin DW. PMID: 19758683.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansPHPublic Health
    309. Predictive value of serial measurements of quality of life on all-cause mortality in prostate cancer patients: data from CaPSURE (cancer of the prostate strategic urologic research endeavor) database. Qual Life Res. 2009 Oct; 18(8):1019-27. Sadetsky N, Hubbard A, Carroll PR, Satariano W. PMID: 19697155.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    310. The independent value of tumour volume in a contemporary cohort of men treated with radical prostatectomy for clinically localized disease. BJU Int. 2010 Feb; 105(4):472-5. Porten SP, Cooperberg MR, Carroll PR. PMID: 19681901.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    311. Risk assessment among prostate cancer patients receiving primary androgen deprivation therapy. J Clin Oncol. 2009 Sep 10; 27(26):4306-13. Cooperberg MR, Hinotsu S, Namiki M, Ito K, Broering J, Carroll PR, Akaza H. PMID: 19667269.
      View in: PubMed   Mentions: 36     Fields:    Translation:Humans
    312. Prostate-cancer screening. N Engl J Med. 2009 Jul 09; 361(2):203; author reply 204-5. Cooperberg MR, Carroll PR. PMID: 19593852.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansPHPublic Health
    313. Adequacy of lymphadenectomy among men undergoing robot-assisted laparoscopic radical prostatectomy. BJU Int. 2010 Jan; 105(1):88-92. Cooperberg MR, Kane CJ, Cowan JE, Carroll PR. PMID: 19549119.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    314. Risk assessment for prostate cancer metastasis and mortality at the time of diagnosis. J Natl Cancer Inst. 2009 Jun 16; 101(12):878-87. Cooperberg MR, Broering JM, Carroll PR. PMID: 19509351.
      View in: PubMed   Mentions: 81     Fields:    Translation:Humans
    315. The impact of obesity on overall and cancer specific survival in men with prostate cancer. J Urol. 2009 Jul; 182(1):112-7; discussion 117. Davies BJ, Smaldone MC, Sadetsky N, Dall'era M, Carroll PR. PMID: 19447437.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    316. Outcomes and follow-up strategies for patients on active surveillance. Curr Opin Urol. 2009 May; 19(3):258-62. Dall'Era MA, Carroll PR. PMID: 19295434.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansPHPublic Health
    317. ACR appropriateness criteria on external beam radiation therapy treatment planning for clinically localized prostate cancer expert panel on radiation oncology--prostate. Int J Radiat Oncol Biol Phys. 2009 Jul 01; 74(3):667-72. Michalski JM, Roach M, Merrick G, Anscher MS, Beyer DC, Lawton CA, Lee WR, Pollack A, Rosenthal SA, Vijayakumar S, Carroll PR. PMID: 19386445.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    318. The importance of tumor palpability and transrectal ultrasonographic appearance in the contemporary clinical staging of prostate cancer. Urol Oncol. 2011 Mar-Apr; 29(2):171-6. Eisenberg ML, Cowan JE, Davies BJ, Carroll PR, Shinohara K. PMID: 19362864.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    319. Prognostic implications of an undetectable ultrasensitive prostate-specific antigen level after radical prostatectomy. Eur Urol. 2010 Apr; 57(4):622-9. Eisenberg ML, Davies BJ, Cooperberg MR, Cowan JE, Carroll PR. PMID: 19375843.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    320. Surveillance of urothelial carcinoma: stage and grade migration, 1993-2005 and survival trends, 1993-2000. Cancer. 2009 Apr 01; 115(7):1435-47. David KA, Mallin K, Milowsky MI, Ritchey J, Carroll PR, Nanus DM. PMID: 19215030.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    321. Carboxypeptidase 4 gene variants and early-onset intermediate-to-high risk prostate cancer. BMC Cancer. 2009 Feb 26; 9:69. Ross PL, Cheng I, Liu X, Cicek MS, Carroll PR, Casey G, Witte JS. PMID: 19245716.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    322. Maximum vs. mono androgen blockade and the risk of recurrence in men with localized prostate cancer undergoing brachytherapy. Int J Radiat Oncol Biol Phys. 2009 Sep 01; 75(1):36-9. Chen RC, Sadetsky N, Chen MH, Carroll PR, D'Amico AV. PMID: 19233568.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    323. Sociodemographic predictors of prostate cancer risk category at diagnosis: unique patterns of significant and insignificant disease. J Urol. 2009 Apr; 181(4):1622-7; discussion 1627. Dall'era MA, Hosang N, Konety B, Cowan JE, Carroll PR. PMID: 19230923.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    324. Pathological outcomes of candidates for active surveillance of prostate cancer. J Urol. 2009 Apr; 181(4):1628-33; discussion 1633-4. Conti SL, Dall'era M, Fradet V, Cowan JE, Simko J, Carroll PR. PMID: 19233388.
      View in: PubMed   Mentions: 49     Fields:    Translation:HumansPHPublic Health
    325. A multicolour fluorescence in situ hybridization test predicts recurrence in patients with high-risk superficial bladder tumours undergoing intravesical therapy. BJU Int. 2009 Aug; 104(3):336-9. Whitson J, Berry A, Carroll P, Konety B. PMID: 19220253.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    326. Are age-based criteria the best way to determine eligibility for prostate cancer screening? Ann Intern Med. 2009 Feb 03; 150(3):220-1; author reply 221-2. Konety BR, Cooperberg MR, Carroll PR. PMID: 19189916.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansPHPublic Health
    327. Sequential intravesical gemcitabine and mitomycin C chemotherapy regimen in patients with non-muscle invasive bladder cancer. Urol Oncol. 2010 Sep-Oct; 28(5):510-4. Breyer BN, Whitson JM, Carroll PR, Konety BR. PMID: 19171491.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    328. The impact of lymphadenectomy and lymph node metastasis on the outcomes of radical cystectomy for bladder cancer. Eur Urol. 2009 Apr; 55(4):826-35. Karl A, Carroll PR, Gschwend JE, Knüchel R, Montorsi F, Stief CG, Studer UE. PMID: 19150582.
      View in: PubMed   Mentions: 45     Fields:    Translation:Humans
    329. Geographic distribution of urologists throughout the United States using a county level approach. J Urol. 2009 Feb; 181(2):760-5; discussion 765-6. Odisho AY, Fradet V, Cooperberg MR, Ahmad AE, Carroll PR. PMID: 19091334.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    330. The clinical impact of an early decline in kidney function in patients following heart transplantation. Am J Transplant. 2009 Feb; 9(2):348-54. Cantarovich M, Hirsh A, Alam A, Giannetti N, Cecere R, Carroll P, Edwardes ME. PMID: 19120080.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    331. Evaluating localized prostate cancer and identifying candidates for focal therapy. Urology. 2008 Dec; 72(6 Suppl):S12-24. Sartor AO, Hricak H, Wheeler TM, Coleman J, Penson DF, Carroll PR, Rubin MA, Scardino PT. PMID: 19095124.
      View in: PubMed   Mentions: 47     Fields:    Translation:Humans
    332. Conventional treatments of localized prostate cancer. Urology. 2008 Dec; 72(6 Suppl):S25-35. Zerbib M, Zelefsky MJ, Higano CS, Carroll PR. PMID: 19095125.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    333. New treatments for localized prostate cancer. Urology. 2008 Dec; 72(6 Suppl):S36-43. Marberger M, Carroll PR, Zelefsky MJ, Coleman JA, Hricak H, Scardino PT, Abenhaim LL. PMID: 19095127.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    334. Pretreatment predictors of death from other causes in men with prostate cancer. J Urol. 2008 Dec; 180(6):2447-51; discussion 2451-2. Simone NL, Singh AK, Cowan JE, Soule BP, Carroll PR, Litwin MS. PMID: 18930498.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    335. Health related quality of life in patients treated with multimodal therapy for prostate cancer. J Urol. 2008 Dec; 180(6):2415-22; discussion 2422. Wu AK, Cooperberg MR, Sadetsky N, Carroll PR. PMID: 18930279.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    336. Quality of life in men with locally advanced adenocarcinoma of the prostate: an exploratory analysis using data from the CaPSURE database. J Urol. 2008 Dec; 180(6):2409-13; discussion 2414. White WM, Sadetsky N, Waters WB, Carroll PR, Litwin MS. PMID: 18930270.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    337. Androgen deprivation therapy for the treatment of prostate cancer: consider both benefits and risks. Eur Urol. 2009 Jan; 55(1):62-75. Isbarn H, Boccon-Gibod L, Carroll PR, Montorsi F, Schulman C, Smith MR, Sternberg CN, Studer UE. PMID: 18945543.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    338. Impact of radical prostatectomy positive surgical margins on fear of cancer recurrence: results from CaPSURE. Urol Oncol. 2010 May-Jun; 28(3):268-73. Hong YM, Hu JC, Paciorek AT, Knight SJ, Carroll PR. PMID: 18848785.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    339. Increased telomerase activity and comprehensive lifestyle changes: a pilot study. Lancet Oncol. 2008 Nov; 9(11):1048-57. Ornish D, Lin J, Daubenmier J, Weidner G, Epel E, Kemp C, Magbanua MJ, Marlin R, Yglecias L, Carroll PR, Blackburn EH. PMID: 18799354.
      View in: PubMed   Mentions: 101     Fields:    Translation:HumansCellsCTClinical Trials
    340. An oncogenic role for the multiple endocrine neoplasia type 1 gene in prostate cancer. Prostate Cancer Prostatic Dis. 2009; 12(2):184-91. Paris PL, Sridharan S, Hittelman AB, Kobayashi Y, Perner S, Huang G, Simko J, Carroll P, Rubin MA, Collins C. PMID: 18779856.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    341. What percentage of patients with newly diagnosed carcinoma of the prostate are candidates for surveillance? An analysis of the CaPSURE database. J Urol. 2008 Oct; 180(4):1330-4; discussion 1334-5. Barocas DA, Cowan JE, Smith JA, Carroll PR. PMID: 18707731.
      View in: PubMed   Mentions: 41     Fields:    Translation:Humans
    342. Clinical events in prostate cancer lifestyle trial: results from two years of follow-up. Urology. 2008 Dec; 72(6):1319-23. Frattaroli J, Weidner G, Dnistrian AM, Kemp C, Daubenmier JJ, Marlin RO, Crutchfield L, Yglecias L, Carroll PR, Ornish D. PMID: 18602144.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansCells
    343. Quantification of choline- and ethanolamine-containing metabolites in human prostate tissues using 1H HR-MAS total correlation spectroscopy. Magn Reson Med. 2008 Jul; 60(1):33-40. Swanson MG, Keshari KR, Tabatabai ZL, Simko JP, Shinohara K, Carroll PR, Zektzer AS, Kurhanewicz J. PMID: 18581409.
      View in: PubMed   Mentions: 37     Fields:    Translation:Humans
    344. Renal cell cancer stage migration: analysis of the National Cancer Data Base. Cancer. 2008 Jul 01; 113(1):78-83. Kane CJ, Mallin K, Ritchey J, Cooperberg MR, Carroll PR. PMID: 18491376.
      View in: PubMed   Mentions: 119     Fields:    Translation:Humans
    345. Changes in prostate gene expression in men undergoing an intensive nutrition and lifestyle intervention. Proc Natl Acad Sci U S A. 2008 Jun 17; 105(24):8369-74. Ornish D, Magbanua MJ, Weidner G, Weinberg V, Kemp C, Green C, Mattie MD, Marlin R, Simko J, Shinohara K, Haqq CM, Carroll PR. PMID: 18559852.
      View in: PubMed   Mentions: 56     Fields:    Translation:HumansCells
    346. Active surveillance for the management of prostate cancer in a contemporary cohort. Cancer. 2008 Jun 15; 112(12):2664-70. Dall'Era MA, Konety BR, Cowan JE, Shinohara K, Stauf F, Cooperberg MR, Meng MV, Kane CJ, Perez N, Master VA, Carroll PR. PMID: 18433013.
      View in: PubMed   Mentions: 103     Fields:    Translation:HumansCTClinical Trials
    347. Decreasing size at diagnosis of stage 1 renal cell carcinoma: analysis from the National Cancer Data Base, 1993 to 2004. J Urol. 2008 Jun; 179(6):2131-5. Cooperberg MR, Mallin K, Ritchey J, Villalta JD, Carroll PR, Kane CJ. PMID: 18423754.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    348. Prostate cancer: is inapparent tumor at endorectal MR and MR spectroscopic imaging a favorable prognostic finding in patients who select active surveillance? Radiology. 2008 May; 247(2):444-50. Cabrera AR, Coakley FV, Westphalen AC, Lu Y, Zhao S, Shinohara K, Carroll PR, Kurhanewicz J. PMID: 18430877.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    349. Watchful waiting and health related quality of life for patients with localized prostate cancer: data from CaPSURE. J Urol. 2008 May; 179(5 Suppl):S14-8. Arredondo SA, Downs TM, Lubeck DP, Pasta DJ, Silva SJ, Wallace KL, Carroll PR. PMID: 18405740.
      View in: PubMed   Mentions: 1     Fields:    
    350. Active surveillance for early-stage prostate cancer: review of the current literature. Cancer. 2008 Apr 15; 112(8):1650-9. Dall'Era MA, Cooperberg MR, Chan JM, Davies BJ, Albertsen PC, Klotz LH, Warlick CA, Holmberg L, Bailey DE, Wallace ME, Kantoff PW, Carroll PR. PMID: 18306379.
      View in: PubMed   Mentions: 87     Fields:    Translation:HumansPHPublic Health
    351. High-risk prostate cancer in the United States, 1990-2007. World J Urol. 2008 Jun; 26(3):211-8. Cooperberg MR, Cowan J, Broering JM, Carroll PR. PMID: 18369637.
      View in: PubMed   Mentions: 39     Fields:    Translation:Humans
    352. Racial differences among boys with testicular germ cell tumors in the United States. J Urol. 2008 May; 179(5):1961-5. Walsh TJ, Davies BJ, Croughan MS, Carroll PR, Turek PJ. PMID: 18355842.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    353. Fear of recurrence, symptom burden, and health-related quality of life in men with prostate cancer. Urology. 2008 Dec; 72(6):1269-73. Bellizzi KM, Latini DM, Cowan JE, DuChane J, Carroll PR. PMID: 18342930.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    354. Sex differences in renal cell cancer presentation and survival: an analysis of the National Cancer Database, 1993-2004. J Urol. 2008 May; 179(5):1709-13; discussion 1713. Woldrich JM, Mallin K, Ritchey J, Carroll PR, Kane CJ. PMID: 18343430.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    355. Patterns of primary and secondary therapy for prostate cancer in elderly men: analysis of data from CaPSURE. J Urol. 2008 May; 179(5):1797-803; discussion 1803. Konety BR, Cowan JE, Carroll PR. PMID: 18343440.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    356. Insurance and quality of life in men with prostate cancer: data from the Cancer of the Prostate Strategic Urological Research Endeavor. BJU Int. 2008 Mar; 101(6):691-7. Sadetsky N, Lubeck DP, Pasta DJ, Latini DM, DuChane J, Carroll PR. PMID: 18291018.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    357. Effect of BMI on primary treatment of prostate cancer. Urology. 2008 Aug; 72(2):406-11. Davies BJ, Walsh TJ, Ross PL, Knight SJ, Sadetsky N, Carroll PR, Kane CJ. PMID: 18267336.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    358. A model that predicts the probability of positive imaging in prostate cancer cases with biochemical failure after initial definitive local therapy. J Urol. 2008 Mar; 179(3):906-10; discussion 910. Choueiri TK, Dreicer R, Paciorek A, Carroll PR, Konety B. PMID: 18207194.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    359. The impact of treatment choice for localized prostate cancer on response to phosphodiesterase inhibitors. J Urol. 2008 Mar; 179(3):1072-6; discussion 1076. Lee IH, Sadetsky N, Carroll PR, Sandler HM. PMID: 18206926.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    360. Treatment failure after primary and salvage therapy for prostate cancer: likelihood, patterns of care, and outcomes. Cancer. 2008 Jan 15; 112(2):307-14. Agarwal PK, Sadetsky N, Konety BR, Resnick MI, Carroll PR. PMID: 18050294.
      View in: PubMed   Mentions: 76     Fields:    Translation:Humans
    361. Multiparametric magnetic resonance imaging in prostate cancer: present and future. Curr Opin Urol. 2008 Jan; 18(1):71-7. Kurhanewicz J, Vigneron D, Carroll P, Coakley F. PMID: 18090494.
      View in: PubMed   Mentions: 71     Fields:    Translation:Humans
    362. Time to prostate-specific antigen nadir after androgen suppression therapy for postoperative or postradiation PSA failure and risk of prostate cancer-specific mortality. Urology. 2008 Jan; 71(1):136-40. Chung CS, Chen MH, Cullen J, McLeod D, Carroll P, D'Amico AV. PMID: 18242382.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    363. Predicting PSA failure following salvage radiotherapy for a rising PSA post-prostatectomy: from the CaPSURE database. Urol Oncol. 2008 May-Jun; 26(3):271-5. Macdonald OK, D'Amico AV, Sadetsky N, Shrieve DC, Carroll PR. PMID: 18452818.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    364. Prostate cancer in the Baby Boomer generation: results from CaPSURE. Urology. 2007 Dec; 70(6):1162-7. Scales CD, Moul JW, Curtis LH, Elkin EP, Hughes ME, Carroll PR. PMID: 18158039.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    365. Peripheral zone prostate cancer: accuracy of different interpretative approaches with MR and MR spectroscopic imaging. Radiology. 2008 Jan; 246(1):177-84. Westphalen AC, Coakley FV, Qayyum A, Swanson M, Simko JP, Lu Y, Zhao S, Carroll PR, Yeh BM, Kurhanewicz J. PMID: 18024434.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    366. Prostate biopsy patterns in the CaPSURE database: evolution with time and impact on outcome after prostatectomy. J Urol. 2008 Jan; 179(1):136-40. Shah JB, McKiernan JM, Elkin EP, Carroll PR, Meng MV. PMID: 17997437.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    367. Focal therapy for localized prostate cancer: a critical appraisal of rationale and modalities. J Urol. 2007 Dec; 178(6):2260-7. Eggener SE, Scardino PT, Carroll PR, Zelefsky MJ, Sartor O, Hricak H, Wheeler TM, Fine SW, Trachtenberg J, Rubin MA, Ohori M, Kuroiwa K, Rossignol M, Abenhaim L. PMID: 17936815.
      View in: PubMed   Mentions: 65     Fields:    Translation:Humans
    368. Androgen deprivation therapy for localized prostate cancer and the risk of cardiovascular mortality. J Natl Cancer Inst. 2007 Oct 17; 99(20):1516-24. Tsai HK, D'Amico AV, Sadetsky N, Chen MH, Carroll PR. PMID: 17925537.
      View in: PubMed   Mentions: 113     Fields:    Translation:Humans
    369. Prostate cancer outcomes among older men: insurance status comparisons results from CaPSURE database. Prostate Cancer Prostatic Dis. 2008; 11(3):280-7. Sadetsky N, Elkin EP, Latini DM, DuChane J, Carroll PR. PMID: 17893700.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    370. Prepubertal orchiopexy for cryptorchidism may be associated with lower risk of testicular cancer. J Urol. 2007 Oct; 178(4 Pt 1):1440-6; discussion 1446. Walsh TJ, Dall'Era MA, Croughan MS, Carroll PR, Turek PJ. PMID: 17706709.
      View in: PubMed   Mentions: 35     Fields:    Translation:Humans
    371. Prostate-specific antigen level at initiation of hormonal therapy after prostate-specific antigen failure following prostatectomy or radiotherapy and therapeutic response. Urology. 2007 Aug; 70(2):320-3. Alexander BM, Chen MH, Carroll P, D'Amico AV. PMID: 17826497.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    372. Prostate cancer early detection. Clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2007 Aug; 5(7):714-36. Kawachi MH, Bahnson RR, Barry M, Carroll PR, Carter HB, Catalona WJ, Epstein JI, Etzioni RB, Hemstreet GP, Howe RJ, Kopin JD, Lange PH, Lilja H, Mohler J, Moul J, Nadler RB, Patterson S, Pollack A, Presti JC, Stroup AM, Urban DA, Wake R, Wei JT. PMID: 17692177.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    373. Innovations and challenges in prostate cancer: summary statement for the 6th Cambridge Conference. J Urol. 2007 Sep; 178(3 Pt 2):S5-8; quiz S4. Kantoff PW, Beer TM, D'Amico AV, Dipaola RS, Eisenberger MA, Hussain MH, Kelly WK, Mathew P, Morris MJ, Ryan CJ, Sandler HM, Thompson IM, Carroll PR. PMID: 17644118.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    374. Contemporary trends in low risk prostate cancer: risk assessment and treatment. J Urol. 2007 Sep; 178(3 Pt 2):S14-9. Cooperberg MR, Broering JM, Kantoff PW, Carroll PR. PMID: 17644125.
      View in: PubMed   Mentions: 129     Fields:    Translation:Humans
    375. Fear of recurrence, treatment satisfaction, and quality of life after radical prostatectomy for prostate cancer. Support Care Cancer. 2008 Feb; 16(2):161-9. Hart SL, Latini DM, Cowan JE, Carroll PR. PMID: 17638026.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    376. The relationship between anxiety and time to treatment for patients with prostate cancer on surveillance. J Urol. 2007 Sep; 178(3 Pt 1):826-31; discussion 831-2. Latini DM, Hart SL, Knight SJ, Cowan JE, Ross PL, Duchane J, Carroll PR. PMID: 17632144.
      View in: PubMed   Mentions: 53     Fields:    Translation:Humans
    377. Adjuvant radiotherapy in prostate cancer: predictors of prostate-specific antigen recurrence from the CaPSURE database. Urology. 2007 Jul; 70(1):106-10. Macdonald OK, D'Amico AV, Sadetsky N, Shrieve DC, Carroll PR. PMID: 17656218.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    378. Initial treatment patterns and outcome of contemporary prostate cancer patients with bone metastases at initial presentation: data from CaPSURE. Cancer. 2007 Jul 01; 110(1):81-6. Ryan CJ, Elkin EP, Cowan J, Carroll PR. PMID: 17516446.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    379. Incidence of urethral stricture after primary treatment for prostate cancer: data From CaPSURE. J Urol. 2007 Aug; 178(2):529-34; discussion 534. Elliott SP, Meng MV, Elkin EP, McAninch JW, Duchane J, Carroll PR. PMID: 17570425.
      View in: PubMed   Mentions: 53     Fields:    Translation:HumansPHPublic Health
    380. Low incidence of perioperative chemotherapy for stage III bladder cancer 1998 to 2003: a report from the National Cancer Data Base. J Urol. 2007 Aug; 178(2):451-4. David KA, Milowsky MI, Ritchey J, Carroll PR, Nanus DM. PMID: 17561135.
      View in: PubMed   Mentions: 53     Fields:    Translation:Humans
    381. Quality of life in young men after radical prostatectomy. Prostate Cancer Prostatic Dis. 2008; 11(1):67-73. Wright JL, Lin DW, Cowan JE, Carroll PR, Litwin MS. PMID: 17519925.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    382. Education predicts quality of life among men with prostate cancer cared for in the Department of Veterans Affairs: a longitudinal quality of life analysis from CaPSURE. Cancer. 2007 May 01; 109(9):1769-76. Knight SJ, Latini DM, Hart SL, Sadetsky N, Kane CJ, DuChane J, Carroll PR. PMID: 17380491.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    383. Prostate cancer--more information and more questions. J Urol. 2007 May; 177(5):1607-8. Dall'Era M, Carroll PR. PMID: 17437768.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansPHPublic Health
    384. Recovery of urinary continence following radical prostatectomy: the impact of prostate volume--analysis of data from the CaPSURE Database. J Urol. 2007 Apr; 177(4):1423-5; discussion 1425-6. Konety BR, Sadetsky N, Carroll PR. PMID: 17382745.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    385. Prostate brachytherapy: a descriptive analysis from CaPSURE. Brachytherapy. 2007 Apr-Jun; 6(2):123-8. Lee WR, Sharkey J, Cowan JE, DuChane J, Carroll PR. PMID: 17434105.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    386. Time to an undetectable prostate-specific antigen (PSA) after androgen suppression therapy for postoperative or postradiation PSA recurrence and prostate cancer-specific mortality. Cancer. 2007 Apr 01; 109(7):1290-5. D'Amico AV, McLeod DG, Carroll PR, Cullen J, Chen MH. PMID: 17315162.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    387. Bladder cancer incidence and risk factors in men with prostate cancer: results from Cancer of the Prostate Strategic Urologic Research Endeavor. J Urol. 2007 Mar; 177(3):883-7; discussion 887-8. Boorjian S, Cowan JE, Konety BR, DuChane J, Tewari A, Carroll PR, Kane CJ. PMID: 17296367.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    388. Limited pelvic lymph node dissection at the time of radical prostatectomy does not affect 5-year failure rates for low, intermediate and high risk prostate cancer: results from CaPSURE. J Urol. 2007 Feb; 177(2):526-29; discussion 529-30. Berglund RK, Sadetsky N, DuChane J, Carroll PR, Klein EA. PMID: 17222625.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    389. Factors affecting outcomes after radical cystectomy in African Americans. Cancer. 2007 Feb 01; 109(3):542-8. Konety BR, Allareddy V, Carroll PR. PMID: 17200961.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    390. Cumulative cost pattern comparison of prostate cancer treatments. Cancer. 2007 Feb 01; 109(3):518-27. Wilson LS, Tesoro R, Elkin EP, Sadetsky N, Broering JM, Latini DM, DuChane J, Mody RR, Carroll PR. PMID: 17186528.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    391. Validity of prostate-specific antigen as a tumour marker in men with prostate cancer managed by watchful-waiting: correlation with findings at serial endorectal magnetic resonance imaging and spectroscopic imaging. BJU Int. 2007 Jan; 99(1):41-5. Coakley FV, Chen I, Qayyum A, Westphalen AC, Carroll PR, Hricak H, Chen MH, Kurhanewicz J. PMID: 17227490.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    392. Quality of life for men receiving a second treatment for prostate cancer. J Urol. 2007 Jan; 177(1):273-8; discussion 278-9. Arredondo SA, Latini DM, Sadetsky N, Kawakami J, Pasta DJ, DuChane J, Carroll PR. PMID: 17162062.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    393. Relationship of dietary protein and soy isoflavones to serum IGF-1 and IGF binding proteins in the Prostate Cancer Lifestyle Trial. Nutr Cancer. 2007; 58(1):35-42. Dewell A, Weidner G, Sumner MD, Barnard RJ, Marlin RO, Daubenmier JJ, Chi C, Carroll PR, Ornish D. PMID: 17571965.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    394. High-grade prostatic intraepithelial neoplasia in patients with prostate cancer: MR and MR spectroscopic imaging features--initial experience. Radiology. 2007 Feb; 242(2):483-9. Hom JJ, Coakley FV, Simko JP, Lu Y, Qayyum A, Westphalen AC, Schmitt LD, Carroll PR, Kurhanewicz J. PMID: 17179396.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    395. Health-related quality of life for men with prostate cancer and diabetes: a longitudinal analysis from CaPSURE. Urology. 2006 Dec; 68(6):1242-7. Latini DM, Chan JM, Cowan JE, Arredondo SA, Kane CJ, Penson DF, DuChane J, Carroll PR. PMID: 17141841.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    396. Genomic profiling of hormone-naïve lymph node metastases in patients with prostate cancer. Neoplasia. 2006 Dec; 8(12):1083-9. Paris PL, Hofer MD, Albo G, Kuefer R, Gschwend JE, Hautmann RE, Fridyland J, Simko J, Carroll PR, Rubin MA, Collins C. PMID: 17217626.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    397. Cancer-specific mortality after radiation therapy with short-course hormonal therapy or radical prostatectomy in men with localized, intermediate-risk to high-risk prostate cancer. Cancer. 2006 Dec 01; 107(11):2597-603. Tsai HK, Chen MH, McLeod DG, Carroll PR, Richie JP, D'Amico AV. PMID: 17039498.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    398. Recommendations for defining and treating high risk localized prostate cancer. J Urol. 2006 Dec; 176(6 Pt 2):S6-S10; quiz S3-5. Thompson IM, Carroll PR, Carducci MA. PMID: 17084170.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    399. Multiinstitutional validation of the UCSF cancer of the prostate risk assessment for prediction of recurrence after radical prostatectomy. Cancer. 2006 Nov 15; 107(10):2384-91. Cooperberg MR, Freedland SJ, Pasta DJ, Elkin EP, Presti JC, Amling CL, Terris MK, Aronson WJ, Kane CJ, Carroll PR. PMID: 17039503.
      View in: PubMed   Mentions: 37     Fields:    Translation:Humans
    400. Changing patterns of pelvic lymphadenectomy for prostate cancer: results from CaPSURE. J Urol. 2006 Oct; 176(4 Pt 1):1382-6. Kawakami J, Meng MV, Sadetsky N, Latini DM, Duchane J, Carroll PR. PMID: 16952638.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    401. Reduced incidence of bony metastasis at initial prostate cancer diagnosis: data from CaPSURE. Urol Oncol. 2006 Sep-Oct; 24(5):396-402. Ryan CJ, Elkin EP, Small EJ, Duchane J, Carroll P. PMID: 16962488.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    402. Prostate-specific antigen-based serial screening may decrease prostate cancer-specific mortality. Urology. 2006 Aug; 68(2):342-7. Efstathiou JA, Chen MH, Catalona WJ, McLeod DG, Carroll PR, Moul JW, Roehl KA, D'Amico AV. PMID: 16904449.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    403. Impact of increased number of biopsies on the nature of prostate cancer identified. J Urol. 2006 Jul; 176(1):63-8; discussion 69. Meng MV, Elkin EP, DuChane J, Carroll PR. PMID: 16753368.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    404. Laparoscopic versus open cytoreductive nephrectomy in advanced renal-cell carcinoma. J Endourol. 2006 Jul; 20(7):504-8. Eisenberg MS, Meng MV, Master VA, Stoller ML, Rini BI, Carroll PR, Kane CJ. PMID: 16859465.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    405. Quantitative analysis of prostate metabolites using 1H HR-MAS spectroscopy. Magn Reson Med. 2006 Jun; 55(6):1257-64. Swanson MG, Zektzer AS, Tabatabai ZL, Simko J, Jarso S, Keshari KR, Schmitt L, Carroll PR, Shinohara K, Vigneron DB, Kurhanewicz J. PMID: 16685733.
      View in: PubMed   Mentions: 80     Fields:    Translation:HumansCells
    406. Androgen-deprivation therapy as primary treatment for localized prostate cancer: data from Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE). Cancer. 2006 Apr 15; 106(8):1708-14. Kawakami J, Cowan JE, Elkin EP, Latini DM, DuChane J, Carroll PR. PMID: 16544313.
      View in: PubMed   Mentions: 31     Fields:    Translation:Humans
    407. Comorbidity and primary treatment for localized prostate cancer: data from CaPSURE. J Urol. 2006 Apr; 175(4):1326-31. Marr PL, Elkin EP, Arredondo SA, Broering JM, DuChane J, Carroll PR. PMID: 16515991.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    408. Impact of comorbidity on health-related quality of life in men undergoing radical prostatectomy: data from CaPSURE. Urology. 2006 Mar; 67(3):559-65. Arredondo SA, Elkin EP, Marr PL, Latini DM, DuChane J, Litwin MS, Carroll PR. PMID: 16527580.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    409. Modifying urology residency training: time to speed up or slow down? J Urol. 2006 Mar; 175(3 Pt 1):811-2. Carroll PR. PMID: 16469555.
      View in: PubMed   Mentions:    Fields:    
    410. Differences in clinical characteristics and disease-free survival for Latino, African American, and non-Latino white men with localized prostate cancer: data from CaPSURE. Cancer. 2006 Feb 15; 106(4):789-95. Latini DM, Elkin EP, Cooperberg MR, Sadetsky N, Duchane J, Carroll PR. PMID: 16400651.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    411. Elongational flow induced ordering in surfactant micelles and mesophases. J Phys Chem B. 2006 Jan 19; 110(2):1073-82. Penfold J, Staples E, Tucker I, Carroll P, Clayton I, Cowan JS, Lawton G, Amin S, Ferrante A, Ruddock N. PMID: 16471644.
      View in: PubMed   Mentions: 4     Fields:    
    412. Smoking influences aberrant CpG hypermethylation of multiple genes in human prostate carcinoma. Cancer. 2006 Jan 01; 106(1):79-86. Enokida H, Shiina H, Urakami S, Terashima M, Ogishima T, Li LC, Kawahara M, Nakagawa M, Kane CJ, Carroll PR, Igawa M, Dahiya R. PMID: 16323173.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCells
    413. Prostate cancer: endorectal MR imaging and MR spectroscopic imaging--distinction of true-positive results from chance-detected lesions. Radiology. 2006 Jan; 238(1):192-9. Hom JJ, Coakley FV, Simko JP, Qayyum A, Lu Y, Schmitt L, Carroll PR, Kurhanewicz J. PMID: 16373767.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    414. Lifestyle and health-related quality of life of men with prostate cancer managed with active surveillance. Urology. 2006 Jan; 67(1):125-30. Daubenmier JJ, Weidner G, Marlin R, Crutchfield L, Dunn-Emke S, Chi C, Gao B, Carroll P, Ornish D. PMID: 16413347.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansPHPublic Health
    415. Prostate biopsy tumor extent but not location predicts recurrence after radical prostatectomy: results from CaPSURE. J Urol. 2006 Jan; 175(1):125-9; discussion 129. Greene KL, Elkin EP, Karapetian A, Duchane J, Carroll PR, Kane CJ. PMID: 16406887.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    416. Magnetic resonance imaging and spectroscopy of prostate cancer. Rev Urol. 2006; 8 Suppl 1:S4-S10. Carroll PR, Coakley FV, Kurhanewicz J. PMID: 17021625.
      View in: PubMed   Mentions:
    417. Total and specific complementary and alternative medicine use in a large cohort of men with prostate cancer. Urology. 2005 Dec; 66(6):1223-8. Chan JM, Elkin EP, Silva SJ, Broering JM, Latini DM, Carroll PR. PMID: 16360447.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    418. The changing face of prostate cancer. J Clin Oncol. 2005 Nov 10; 23(32):8146-51. Cooperberg MR, Moul JW, Carroll PR. PMID: 16278465.
      View in: PubMed   Mentions: 81     Fields:    Translation:Humans
    419. The independent impact of extended pattern biopsy on prostate cancer stage migration. J Urol. 2005 Nov; 174(5):1789-93; discussion 1793. Master VA, Chi T, Simko JP, Weinberg V, Carroll PR. PMID: 16217288.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    420. Androgen deprivation use with external beam radiation for prostate cancer: results from CaPSURE. J Urol. 2005 Nov; 174(5):1802-7. Park S, Meng MV, Elkin EP, Speight JL, DuChane J, Carroll PR. PMID: 16217291.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    421. Who is the average patient presenting with prostate cancer? Urology. 2005 Nov; 66(5 Suppl):76-82. Greene KL, Cowan JE, Cooperberg MR, Meng MV, DuChane J, Carroll PR. PMID: 16194711.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    422. Impact of obesity on prostate cancer recurrence after radical prostatectomy: data from CaPSURE. Urology. 2005 Nov; 66(5):1060-5. Bassett WW, Cooperberg MR, Sadetsky N, Silva S, DuChane J, Pasta DJ, Chan JM, Anast JW, Carroll PR, Kane CJ. PMID: 16286124.
      View in: PubMed   Mentions: 41     Fields:    Translation:Humans
    423. Promoter CpG hypomethylation and transcription factor EGR1 hyperactivate heparanase expression in bladder cancer. Oncogene. 2005 Oct 13; 24(45):6765-72. Ogishima T, Shiina H, Breault JE, Terashima M, Honda S, Enokida H, Urakami S, Tokizane T, Kawakami T, Ribeiro-Filho LA, Fujime M, Kane CJ, Carroll PR, Igawa M, Dahiya R. PMID: 16007175.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansCells
    424. Bladder cancer stage and outcome by array-based comparative genomic hybridization. Clin Cancer Res. 2005 Oct 01; 11(19 Pt 1):7012-22. Blaveri E, Brewer JL, Roydasgupta R, Fridlyand J, DeVries S, Koppie T, Pejavar S, Mehta K, Carroll P, Simko JP, Waldman FM. PMID: 16203795.
      View in: PubMed   Mentions: 51     Fields:    Translation:HumansCells
    425. Ethnic and racial differences in prostate stromal estrogen receptor alpha. Prostate. 2005 Oct 01; 65(2):101-9. Haqq C, Li R, Khodabakhsh D, Frolov A, Ginzinger D, Thompson T, Wheeler T, Carroll P, Ayala G. PMID: 15880569.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    426. Predictors of prostate cancer-specific mortality after radical prostatectomy or radiation therapy. J Clin Oncol. 2005 Oct 01; 23(28):6992-8. Zhou P, Chen MH, McLeod D, Carroll PR, Moul JW, D'Amico AV. PMID: 16192586.
      View in: PubMed   Mentions: 47     Fields:    Translation:Humans
    427. Prostate-specific antigen nadir and cancer-specific mortality following hormonal therapy for prostate-specific antigen failure. J Clin Oncol. 2005 Sep 20; 23(27):6556-60. Stewart AJ, Scher HI, Chen MH, McLeod DG, Carroll PR, Moul JW, D'Amico AV. PMID: 16170163.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    428. Multigene methylation analysis for detection and staging of prostate cancer. Clin Cancer Res. 2005 Sep 15; 11(18):6582-8. Enokida H, Shiina H, Urakami S, Igawa M, Ogishima T, Li LC, Kawahara M, Nakagawa M, Kane CJ, Carroll PR, Dahiya R. PMID: 16166436.
      View in: PubMed   Mentions: 35     Fields:    Translation:HumansCells
    429. History of diabetes, clinical features of prostate cancer, and prostate cancer recurrence-data from CaPSURE (United States). Cancer Causes Control. 2005 Sep; 16(7):789-97. Chan JM, Latini DM, Cowan J, Duchane J, Carroll PR. PMID: 16132789.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    430. Intensive lifestyle changes may affect the progression of prostate cancer. J Urol. 2005 Sep; 174(3):1065-9; discussion 1069-70. Ornish D, Weidner G, Fair WR, Marlin R, Pettengill EB, Raisin CJ, Dunn-Emke S, Crutchfield L, Jacobs FN, Barnard RJ, Aronson WJ, McCormac P, McKnight DJ, Fein JD, Dnistrian AM, Weinstein J, Ngo TH, Mendell NR, Carroll PR. PMID: 16094059.
      View in: PubMed   Mentions: 82     Fields:    Translation:HumansCellsCTClinical Trials
    431. Ethnic group-related differences in CpG hypermethylation of the GSTP1 gene promoter among African-American, Caucasian and Asian patients with prostate cancer. Int J Cancer. 2005 Aug 20; 116(2):174-81. Enokida H, Shiina H, Urakami S, Igawa M, Ogishima T, Pookot D, Li LC, Tabatabai ZL, Kawahara M, Nakagawa M, Kane CJ, Carroll PR, Dahiya R. PMID: 15800905.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansCells
    432. Management of isolated renal fossa recurrence following radical nephrectomy. J Urol. 2005 Aug; 174(2):473-7; discussion 477. Master VA, Gottschalk AR, Kane C, Carroll PR. PMID: 16006867.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    433. Preliminary evaluation of prostate cancer metastatic risk biomarkers. Int J Biol Markers. 2005 Jul-Sep; 20(3):141-5. Paris PL, Weinberg V, Simko J, Andaya A, Albo G, Rubin MA, Carroll PR, Collins C. PMID: 16247872.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    434. CpG methylation at promoter site -140 inactivates TGFbeta2 receptor gene in prostate cancer. Cancer. 2005 Jul 01; 104(1):44-52. Zhao H, Shiina H, Greene KL, Li LC, Tanaka Y, Kishi H, Igawa M, Kane CJ, Carroll P, Dahiya R. PMID: 15895377.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCells
    435. Update on chemotherapy for advanced bladder cancer. J Urol. 2005 Jul; 174(1):14-20. Rosenberg JE, Carroll PR, Small EJ. PMID: 15947569.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    436. Clinical and pathological characteristics of unstageable prostate cancer: analysis of the CaPSURE database. J Urol. 2005 Jul; 174(1):118-20. Langenstroer P, Carroll P, Thrasher JB. PMID: 15947594.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    437. Bladder cancer outcome and subtype classification by gene expression. Clin Cancer Res. 2005 Jun 01; 11(11):4044-55. Blaveri E, Simko JP, Korkola JE, Brewer JL, Baehner F, Mehta K, Devries S, Koppie T, Pejavar S, Carroll P, Waldman FM. PMID: 15930339.
      View in: PubMed   Mentions: 97     Fields:    Translation:HumansCells
    438. The University of California, San Francisco Cancer of the Prostate Risk Assessment score: a straightforward and reliable preoperative predictor of disease recurrence after radical prostatectomy. J Urol. 2005 Jun; 173(6):1938-42. Cooperberg MR, Pasta DJ, Elkin EP, Litwin MS, Latini DM, Du Chane J, Carroll PR. PMID: 15879786.
      View in: PubMed   Mentions: 149     Fields:    Translation:Humans
    439. Multidisciplinary management of advanced prostate cancer: changing perspectives on referring patients and enhancing collaboration between oncologists and urologists in clinical trials. Urology. 2005 May; 65(5 Suppl):18-22; discussion 22. Carducci MA, Carroll PR. PMID: 15885275.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    440. Treatment of patients with high risk localized prostate cancer: results from cancer of the prostate strategic urological research endeavor (CaPSURE). J Urol. 2005 May; 173(5):1557-61. Meng MV, Elkin EP, Latini DM, Duchane J, Carroll PR. PMID: 15821485.
      View in: PubMed   Mentions: 36     Fields:    Translation:Humans
    441. Surrogate end point for prostate cancer specific mortality in patients with nonmetastatic hormone refractory prostate cancer. J Urol. 2005 May; 173(5):1572-6. D'Amico AV, Moul J, Carroll PR, Sun L, Lubeck D, Chen MH. PMID: 15821488.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    442. Ability of 2 pretreatment risk assessment methods to predict prostate cancer recurrence after radical prostatectomy: data from CaPSURE. J Urol. 2005 Apr; 173(4):1126-31. Mitchell JA, Cooperberg MR, Elkin EP, Lubeck DP, Mehta SS, Kane CJ, Carroll PR. PMID: 15758720.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    443. The impact of obesity on health related quality of life before and after radical prostatectomy (data from CaPSURE). J Urol. 2005 Apr; 173(4):1132-8. Anast JW, Sadetsky N, Pasta DJ, Bassett WW, Latini D, DuChane J, Chan JM, Cooperberg MR, Carroll PR, Kane CJ. PMID: 15758721.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    444. Early stage prostate cancer--do we have a problem with over-detection, overtreatment or both? J Urol. 2005 Apr; 173(4):1061-2. Carroll PR. PMID: 15758699.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansPHPublic Health
    445. CXCR4 expression reflects tumor progression and regulates motility of bladder cancer cells. Int J Cancer. 2005 Mar 20; 114(2):182-9. Retz MM, Sidhu SS, Blaveri E, Kerr SC, Dolganov GM, Lehmann J, Carroll P, Simko J, Waldman FM, Basbaum C. PMID: 15540205.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    446. Functional Loss of the gamma-catenin gene through epigenetic and genetic pathways in human prostate cancer. Cancer Res. 2005 Mar 15; 65(6):2130-8. Shiina H, Breault JE, Basset WW, Enokida H, Urakami S, Li LC, Okino ST, Deguchi M, Kaneuchi M, Terashima M, Yoneda T, Shigeno K, Carroll PR, Igawa M, Dahiya R. PMID: 15781623.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCells
    447. Obesity and prostate cancer clinical risk factors at presentation: data from CaPSURE. J Urol. 2005 Mar; 173(3):732-6. Kane CJ, Bassett WW, Sadetsky N, Silva S, Wallace K, Pasta DJ, Cooperberg MR, Chan JM, Carroll PR. PMID: 15711258.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    448. Lifestyle correlates of health perception and treatment satisfaction in a clinical cohort of men with prostate cancer. Clin Prostate Cancer. 2005 Mar; 3(4):239-45. Sheriff SK, Shohara RA, Dumican SB, Small EJ, Carroll PR, Chan JM. PMID: 15882480.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    449. Demographics, insurance coverage, and utilization of medical services in newly diagnosed prostate cancer: data from caPSURE. Manag Care Interface. 2005 Feb; 18(2):25-30. Sadetsky N, Lubeck DP, Latini DM, Pasta DJ, Kawakami J, DuChane J, Carroll PR. PMID: 15766061.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    450. Epigenetic changes in prostate cancer: implication for diagnosis and treatment. J Natl Cancer Inst. 2005 Jan 19; 97(2):103-15. Li LC, Carroll PR, Dahiya R. PMID: 15657340.
      View in: PubMed   Mentions: 83     Fields:    Translation:HumansCells
    451. Methylation of the gamma-catenin gene is associated with poor prognosis of renal cell carcinoma. Clin Cancer Res. 2005 Jan 15; 11(2 Pt 1):557-64. Breault JE, Shiina H, Igawa M, Ribeiro-Filho LA, Deguchi M, Enokida H, Urakami S, Terashima M, Nakagawa M, Kane CJ, Carroll PR, Dahiya R. PMID: 15701841.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCells
    452. Inactivation of the hMSH3 mismatch repair gene in bladder cancer. Biochem Biophys Res Commun. 2004 Dec 17; 325(3):934-42. Kawakami T, Shiina H, Igawa M, Deguchi M, Nakajima K, Ogishima T, Tokizane T, Urakami S, Enokida H, Miura K, Ishii N, Kane CJ, Carroll PR, Dahiya R. PMID: 15541380.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    453. Ferromagnetic thermal ablation of locally recurrent prostate cancer: prostate specific antigen results and immediate/intermediate morbidities. J Urol. 2004 Dec; 172(6 Pt 1):2197-202. Master VA, Shinohara K, Carroll PR. PMID: 15538231.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    454. Prostate depiction at endorectal MR spectroscopic imaging: investigation of a standardized evaluation system. Radiology. 2004 Dec; 233(3):701-8. Jung JA, Coakley FV, Vigneron DB, Swanson MG, Qayyum A, Weinberg V, Jones KD, Carroll PR, Kurhanewicz J. PMID: 15564406.
      View in: PubMed   Mentions: 48     Fields:    Translation:Humans
    455. Kidney gene database: a curated and integrated database of genes involved in kidney disease. J Urol. 2004 Dec; 172(6 Pt 1):2344-6. Zhao H, Li LC, Okino ST, Kane CJ, Carroll PR, Dahiya R. PMID: 15538263.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    456. Longitudinal assessment of changes in sexual function and bother in patients treated with external beam radiotherapy or brachytherapy, with and without neoadjuvant androgen ablation: data from CaPSURE. Int J Radiat Oncol Biol Phys. 2004 Nov 15; 60(4):1066-75. Speight JL, Elkin EP, Pasta DJ, Silva S, Lubeck DP, Carroll PR, Litwin MS. PMID: 15519776.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    457. Watchful waiting and health related quality of life for patients with localized prostate cancer: data from CaPSURE. J Urol. 2004 Nov; 172(5 Pt 1):1830-4. Arredondo SA, Downs TM, Lubeck DP, Pasta DJ, Silva SJ, Wallace KL, Carroll PR. PMID: 15540732.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    458. The relative impact and future burden of prostate cancer in the United States. J Urol. 2004 Nov; 172(5 Pt 2):S13-6; discussion S17. Chan JM, Jou RM, Carroll PR. PMID: 15535436.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    459. Fourth International Conference on Innovations and Challenges in Prostate Cancer: Prevention, Detection and Treatment. J Urol. 2004 Nov; 172(5 Pt 2):S3-5. Carroll PR, Chan JM, D'Amico AV, Gelmann EP, Iversen P, Klotz L, Nelson JB, Nelson PS, Nelson WG, Oh WK, Rosen N, Rubin MA, Sandler H, Sellers WR, Smith MR, Xu J, McMann MC, Kantoff PW. PMID: 15535434.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    460. Prostate specific antigen doubling time as a surrogate end point for prostate cancer specific mortality following radical prostatectomy or radiation therapy. J Urol. 2004 Nov; 172(5 Pt 2):S42-6; discussion S46-7. D'Amico AV, Moul J, Carroll PR, Sun L, Lubeck D, Chen MH. PMID: 15535442.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    461. The impact of patient advocacy: the University of California-San Francisco experience. J Urol. 2004 Nov; 172(5 Pt 2):S58-61; discussion S61-2. Carroll PR. PMID: 15535445.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    462. Molecular analysis of WFDC1/ps20 gene in prostate cancer. Prostate. 2004 Oct 01; 61(2):192-9. Watson JE, Kamkar S, James K, Kowbel D, Andaya A, Paris PL, Simko J, Carroll P, McAlhany S, Rowley D, Collins C. PMID: 15305342.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    463. Organ-confined prostate cancer: effect of prior transrectal biopsy on endorectal MRI and MR spectroscopic imaging. AJR Am J Roentgenol. 2004 Oct; 183(4):1079-83. Qayyum A, Coakley FV, Lu Y, Olpin JD, Wu L, Yeh BM, Carroll PR, Kurhanewicz J. PMID: 15385308.
      View in: PubMed   Mentions: 40     Fields:    Translation:Humans
    464. CpG hypermethylation of MDR1 gene contributes to the pathogenesis and progression of human prostate cancer. Cancer Res. 2004 Sep 01; 64(17):5956-62. Enokida H, Shiina H, Igawa M, Ogishima T, Kawakami T, Bassett WW, Anast JW, Li LC, Urakami S, Terashima M, Verma M, Kawahara M, Nakagawa M, Kane CJ, Carroll PR, Dahiya R. PMID: 15342374.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansCells
    465. Prostate cancer 2004: insights from national disease registries. Oncology (Williston Park). 2004 Sep; 18(10):1239-47; discussion 1248-50, 1256-8. Cooperberg MR, Park S, Carroll PR. PMID: 15526829.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    466. Distribution of a single nucleotide polymorphism on codon 211 of the androgen receptor gene and its correlation with human renal cell cancer in Japanese patients. Biochem Biophys Res Commun. 2004 Aug 20; 321(2):468-71. Sasaki M, Nomoto M, Yonezawa S, Nakagawa M, Sakuragi N, Fujimoto S, Carroll PR, Dahiya R. PMID: 15358199.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    467. Age-dependent methylation of ESR1 gene in prostate cancer. Biochem Biophys Res Commun. 2004 Aug 20; 321(2):455-61. Li LC, Shiina H, Deguchi M, Zhao H, Okino ST, Kane CJ, Carroll PR, Igawa M, Dahiya R. PMID: 15358197.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCells
    468. Validation of the Kattan preoperative nomogram for prostate cancer recurrence using a community based cohort: results from cancer of the prostate strategic urological research endeavor (capsure). J Urol. 2004 Jun; 171(6 Pt 1):2255-9. Greene KL, Meng MV, Elkin EP, Cooperberg MR, Pasta DJ, Kattan MW, Wallace K, Carroll PR. PMID: 15126797.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    469. Patterns of practice in the United States: insights from CaPSURE on prostate cancer management. Curr Urol Rep. 2004 Jun; 5(3):166-72. Cooperberg MR, Broering JM, Latini DM, Litwin MS, Wallace KL, Carroll PR. PMID: 15161564.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    470. The changing face of low-risk prostate cancer: trends in clinical presentation and primary management. J Clin Oncol. 2004 Jun 01; 22(11):2141-9. Cooperberg MR, Lubeck DP, Meng MV, Mehta SS, Carroll PR. PMID: 15169800.
      View in: PubMed   Mentions: 141     Fields:    Translation:Humans
    471. Whole genome scanning identifies genotypes associated with recurrence and metastasis in prostate tumors. Hum Mol Genet. 2004 Jul 01; 13(13):1303-13. Paris PL, Andaya A, Fridlyand J, Jain AN, Weinberg V, Kowbel D, Brebner JH, Simko J, Watson JE, Volik S, Albertson DG, Pinkel D, Alers JC, van der Kwast TH, Vissers KJ, Schroder FH, Wildhagen MF, Febbo PG, Chinnaiyan AM, Pienta KJ, Carroll PR, Rubin MA, Collins C, van Dekken H. PMID: 15138198.
      View in: PubMed   Mentions: 54     Fields:    Translation:HumansCells
    472. Mutation of the slow myosin heavy chain rod domain underlies hyaline body myopathy. Neurology. 2004 May 11; 62(9):1518-21. Bohlega S, Abu-Amero SN, Wakil SM, Carroll P, Al-Amr R, Lach B, Al-Sayed Y, Cupler EJ, Meyer BF. PMID: 15136674.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCells
    473. Lifestyle recommendations to prevent prostate cancer, part I: time to redirect our attention? Urol Clin North Am. 2004 May; 31(2):289-300. Moyad MA, Carroll PR. PMID: 15123408.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansPHPublic Health
    474. Lifestyle recommendations to prevent prostate cancer, part II: time to redirect our attention? Urol Clin North Am. 2004 May; 31(2):301-11. Moyad MA, Carroll PR. PMID: 15123409.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansPHPublic Health
    475. Intermediate end point for prostate cancer-specific mortality following salvage hormonal therapy for prostate-specific antigen failure. J Natl Cancer Inst. 2004 Apr 07; 96(7):509-15. D'Amico AV, Moul JW, Carroll PR, Cote K, Sun L, Lubeck D, Renshaw AA, Loffredo M, Chen MH. PMID: 15069112.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    476. Genetic aberrations in prostate carcinoma detected by comparative genomic hybridization and microsatellite analysis: association with progression and angiogenesis. Prostate. 2004 Apr 01; 59(1):43-58. Strohmeyer DM, Berger AP, Moore DH, Bartsch G, Klocker H, Carroll PR, Loening SA, Jensen RH. PMID: 14991865.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    477. The contemporary management of prostate cancer in the United States: lessons from the cancer of the prostate strategic urologic research endeavor (CapSURE), a national disease registry. J Urol. 2004 Apr; 171(4):1393-401. Cooperberg MR, Broering JM, Litwin MS, Lubeck DP, Mehta SS, Henning JM, Carroll PR. PMID: 15017184.
      View in: PubMed   Mentions: 88     Fields:    Translation:Humans
    478. Radical retropubic prostatectomy frustrated by prior laparoscopic mesh herniorrhaphy. Surgery. 2004 Apr; 135(4):452-3; discussion 454. Cooperberg MR, Downs TM, Carroll PR. PMID: 15041971.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    479. Evaluation of the patient with hematuria. Med Clin North Am. 2004 Mar; 88(2):329-43. Yun EJ, Meng MV, Carroll PR. PMID: 15049581.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    480. Treatment and outcome of invasive bladder cancer in patients after renal transplantation. J Urol. 2004 Mar; 171(3):1085-8. Master VA, Meng MV, Grossfeld GD, Koppie TM, Hirose R, Carroll PR. PMID: 14767276.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    481. Laparoscopic partial nephrectomy with temporary arterial occlusion: description of technique and renal functional outcomes. Urology. 2004 Feb; 63(2):241-6. Kane CJ, Mitchell JA, Meng MV, Anast J, Carroll PR, Stoller ML. PMID: 14972462.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    482. Predicting quality of life after radical prostatectomy: results from CaPSURE. J Urol. 2004 Feb; 171(2 Pt 1):703-7; discussion 707-8. Hu JC, Elkin EP, Pasta DJ, Lubeck DP, Kattan MW, Carroll PR, Litwin MS. PMID: 14713791.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    483. Prostate cancer localization with endorectal MR imaging and MR spectroscopic imaging: effect of clinical data on reader accuracy. Radiology. 2004 Jan; 230(1):215-20. Dhingsa R, Qayyum A, Coakley FV, Lu Y, Jones KD, Swanson MG, Carroll PR, Hricak H, Kurhanewicz J. PMID: 14695396.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    484. Patterns of secondary cancer treatment for biochemical failure following radical prostatectomy: data from CaPSURE. J Urol. 2004 Jan; 171(1):215-9. Mehta SS, Lubeck DP, Sadetsky N, Pasta DJ, Carroll PR. PMID: 14665879.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    485. The polyglycine and polyglutamine repeats in the androgen receptor gene in Japanese and Caucasian populations. Biochem Biophys Res Commun. 2003 Dec 26; 312(4):1244-7. Sasaki M, Kaneuchi M, Sakuragi N, Fujimoto S, Carroll PR, Dahiya R. PMID: 14652007.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCellsCTClinical Trials
    486. Third international conference on innovations and challenges in prostate cancer: prevention, detection and treatment. J Urol. 2003 Dec; 170(6 Pt 2):S3-5. Carroll PR, Benaron DA, Blackledge G, Coakley FV, D'Amico AV, Higano CS, Iversen P, Kattan M, Nanus DM, Nelson JB, Oh WK, Roach M, Sellers WR, Smith MR, McMann MC, Kantoff PW. PMID: 14610403.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    487. Time trends in clinical risk stratification for prostate cancer: implications for outcomes (data from CaPSURE). J Urol. 2003 Dec; 170(6 Pt 2):S21-5; discussion S26-7. Cooperberg MR, Lubeck DP, Mehta SS, Carroll PR. PMID: 14610406.
      View in: PubMed   Mentions: 70     Fields:    Translation:HumansPHPublic Health
    488. Predictors of treatment after initial surveillance in men with prostate cancer: results from CaPSURE. J Urol. 2003 Dec; 170(6 Pt 1):2279-83. Meng MV, Elkin EP, Harlan SR, Mehta SS, Lubeck DP, Carroll PR. PMID: 14634396.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    489. The evolving role of androgen deprivation therapy in the management of prostate cancer. Minerva Urol Nefrol. 2003 Dec; 55(4):219-38. Cooperberg MR, Small EJ, D'Amico A, Carroll PR. PMID: 14765015.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    490. Impact of patient educational level on treatment for patients with prostate cancer: data from CaPSURE. Urology. 2003 Dec; 62(6):1035-9. Kane CJ, Lubeck DP, Knight SJ, Spitalny M, Downs TM, Grossfeld GD, Pasta DJ, Mehta SS, Carroll PR. PMID: 14665350.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    491. Health related quality of life patterns in patients treated with interstitial prostate brachytherapy for localized prostate cancer--data from CaPSURE. J Urol. 2003 Nov; 170(5):1822-7. Downs TM, Sadetsky N, Pasta DJ, Grossfeld GD, Kane CJ, Mehta SS, Carroll PR, Lubeck DP. PMID: 14532784.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansPHPublic Health
    492. Proton HR-MAS spectroscopy and quantitative pathologic analysis of MRI/3D-MRSI-targeted postsurgical prostate tissues. Magn Reson Med. 2003 Nov; 50(5):944-54. Swanson MG, Vigneron DB, Tabatabai ZL, Males RG, Schmitt L, Carroll PR, James JK, Hurd RE, Kurhanewicz J. PMID: 14587005.
      View in: PubMed   Mentions: 69     Fields:    Translation:Humans
    493. Time trends and characteristics of men choosing watchful waiting for initial treatment of localized prostate cancer: results from CaPSURE. J Urol. 2003 Nov; 170(5):1804-7. Harlan SR, Cooperberg MR, Elkin E, Lubeck DP, Meng M, Mehta SS, Carroll PR. PMID: 14532780.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    494. Surrogate end point for prostate cancer-specific mortality after radical prostatectomy or radiation therapy. J Natl Cancer Inst. 2003 Sep 17; 95(18):1376-83. D'Amico AV, Moul JW, Carroll PR, Sun L, Lubeck D, Chen MH. PMID: 13130113.
      View in: PubMed   Mentions: 103     Fields:    Translation:Humans
    495. Sociodemographic and clinical risk characteristics of patients with prostate cancer within the Veterans Affairs health care system: data from CaPSURE. J Urol. 2003 Sep; 170(3):905-8. Cooperberg M, Lubeck DP, Penson D, Mehta SS, Carroll PR, Kane CJ. PMID: 12913727.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    496. Mouse urogenital development: a practical approach. Differentiation. 2003 Sep; 71(7):402-13. Staack A, Donjacour AA, Brody J, Cunha GR, Carroll P. PMID: 12969333.
      View in: PubMed   Mentions: 50     Fields:    Translation:Animals
    497. Health related quality of life significance of single pad urinary incontinence following radical prostatectomy. J Urol. 2003 Aug; 170(2 Pt 1):512-5. Cooperberg MR, Master VA, Carroll PR. PMID: 12853811.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    498. National practice patterns and time trends in androgen ablation for localized prostate cancer. J Natl Cancer Inst. 2003 Jul 02; 95(13):981-9. Cooperberg MR, Grossfeld GD, Lubeck DP, Carroll PR. PMID: 12837834.
      View in: PubMed   Mentions: 96     Fields:    Translation:Humans